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Abstract Reactive oxygen species (ROS) are generated
in skeletal muscle both during the rest and contractile
activity. Myogenic cells are equipped with antioxidant
enzymes, like superoxide dismutase, catalase, glutathione
peroxidase, c-glutamylcysteine synthetase and heme oxy-
genase-1. These enzymes not only neutralise excessive
ROS, but also affect myogenic regeneration at several
stages: influence post-injury inflammatory reaction,
enhance viability and proliferation of muscle satellite cells
and myoblasts and affect their differentiation. Finally,
antioxidant enzymes regulate also processes accompanying
muscle regeneration—induce angiogenesis and reduce
fibrosis. Elevated ROS production was also observed in
Duchenne muscular dystrophy (DMD), a disease charac-
terised by degeneration of muscle tissue and therefore—
increased rate of myogenic regeneration. Antioxidant
enzymes are consequently considered as target for thera-
pies counteracting dystrophic symptoms. In this review we
present current knowledge regarding the role of oxidative
stress and systems of enzymatic antioxidant defence in
muscular regeneration after both acute injury and persistent
muscular degeneration.
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Generation of reactive oxygen species in skeletal
muscle
Reactive oxygen species (ROS), highly reactive molecules
due to the presence of unpaired electron, are widely gen-
erated in eukaryotic cells as a result of incomplete, one-
electron reduction of O2 in mitochondria. Uncoupled
transfer of electron from complex I and III in the electron
transport chain (ETC) leads to formation of superoxide
radical (O2
-), which is a primary member of ROS (Droge
2002; Trachootham et al. 2008). During muscle contraction
an increase in oxygen consumption is observed, most of
which is used in ETC and reduced to H2O (Barbieri and
Sestili 2012; Vasilaki and Jackson 2013), but as much as
5 % of O2 was estimated to be converted to O2
- (Lamb and
Westerblad 2011; Sakellariou et al. 2014). Therefore, ini-
tially mitochondria were regarded as a predominant and
primary source of ROS in skeletal muscle tissue (Lamb and
Westerblad 2011; Sakellariou et al. 2014; Vasilaki and
Jackson 2013). However, more recent data reveal that the
rate of electron leakage in ETC during contractile activity
is in fact significantly lower, enabling only 0.15 % of total
oxygen consumption to be reduced to O2
- (Lamb and
Magdalena Kozakowska and Katarzyna Pietraszek-Gremplewicz









1 Department of Medical Biotechnology, Faculty of
Biochemistry, Biophysics and Biotechnology, Jagiellonian
University, Gronostajowa 7, 30-387 Kraków, Poland
2 Malopolska Centre of Biotechnology, Jagiellonian
University, Kraków, Poland
123
J Muscle Res Cell Motil (2015) 36:377–393
DOI 10.1007/s10974-015-9438-9
Westerblad 2011; Powers et al. 2011; Sakellariou et al.
2014; Vasilaki and Jackson 2013).
Concurrently, other metabolic pathways are implicated
in ROS generation in skeletal muscle (Beckendorf and
Linke 2015; Sakellariou et al. 2014), which especially
during contraction, seems to be of cytosol origin (Vasilaki
et al. 2006a). Among them, xanthine oxidase (XO) gener-
ates O2
- as a byproduct of oxidation of hypoxanthine to
xanthine and uric acid (Beckendorf and Linke 2015;
Gomez-Cabrera et al. 2005; Sakellariou et al. 2014). O2
- is
also produced in muscles by lipoxygenases (LOX) during
dioxygenation of arachidonic acid, which is released from
membrane lipids due to phospholipase A2 activity (Powers
et al. 2011; Sakellariou et al. 2014; Zuo et al. 2004).
Finally, nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase (NOX) is a multicomponent enzyme
system that catalyses reduction of O2 to O2
- utilizing
NADH or NADPH as electron donors. There are two iso-
forms of NOX present in skeletal muscle (NOX2, NOX4),
associated with sarcoplasmatic reticulum and sarcolemma,
which are currently considered as a major source of ROS in
striated muscle (Beckendorf and Linke 2015; Powers et al.
2011; Sakellariou et al. 2013; Sakellariou et al. 2014).
Regardless the site of production, O2
- has a relatively
long half-life and does not react directly with proteins,
carbohydrates or nucleic acids, but can serve as a substrate
for generation of secondary ROS. O2
- can be enzymatically
or spontaneously dismutated and becomes, in this manner,
a major cellular source of hydrogen peroxide (H2O2). H2O2
is a non-radical ROS, with a long half-life, permitting its
diffusion both within a cell and across cell membranes.
H2O2 is a weaker oxidising agent than its derivate—pro-
duced in a presence of reduced transition metals, the most
reactive ROS, hydroxyl radical (HO) (Powers et al. 2010;
Powers et al. 2011; Sakellariou et al. 2014; Trachootham
et al. 2008). In spite of that, H2O2 reacts with many dif-
ferent compounds what, in addition to its ability to diffuse,
makes it an important signalling molecule (Powers et al.
2010; Powers et al. 2011; Stone and Yang 2006).
Basically, all reducing groups of main cellular macro-
molecules can be targeted by ROS. Lipids are most sus-
ceptible to HO that, by attacking polyunsaturated fatty acid
lipid residues, generates peroxyl radical, leading to changes
in properties of cellular membranes (Trachootham et al.
2008). Purine and pirimidine bases and deoxyrybose of
DNA are also susceptible to HO (Trachootham et al.
2008). Finally, HO may target amino acid residues of
proteins, especially lysine, arginine, histidine, proline, and
threonine, causing formation of protein carbonyls. Addi-
tionally, sulfur-containing aminoacids are prone to rever-
sible or irreversible oxidation of sulfhydryl groups
(Trachootham et al. 2008). Hence, moderate ROS levels
can modify signal transduction pathways in myogenic
cells. ERK1/2, JNK and p38 kinases are all activated in
response to ROS. Concomitantly, serine/threonine phos-
phatases and phosphotyrosine phosphatases are prone to
oxidation-induced inactivation. These two combined ROS-
promoted events activate different transcription factors and
signalling pathways (Barbieri and Sestili 2012; Powers
et al. 2010). Therefore any disruption in a redox control,
commonly referred as oxidative stress, may lead to not
only macromolecular oxidative damage, but also to potent
changes in signal transduction (Bar-Shai et al. 2008; Bar-
bieri and Sestili 2012; Kramer and Goodyear 2007; Powers
et al. 2010; Powers et al. 2011). Noteworthy, among pro-
teins which expression is dependent on ROS-induced
activation of MAPK and NFjB or AP-1, one can find all
major antioxidant enzymes (Barbieri and Sestili 2012).
Major antioxidant systems in skeletal muscle
It is crucial for a cell to sustain redox homeostasis—
maintain ROS below a threshold level and keep their
function as a signalling molecules, while reducing their
toxic effects (Barbieri and Sestili 2012). Therefore mature
skeletal muscle cell as well as myogenic stem and pro-
genitor cells are equipped with sophisticated enzymatic
antioxidant systems, what renders them extremely flexible
in response to changes in redox milieu (Beckendorf and
Linke 2015; Powers et al. 2011).
A major class of enzymatic antioxidants, which protects
against primary ROS, O2
-, is superoxide dismutase (SOD).
It catalyses transformation of O2
- to H2O2, which can be
subsequently converted to H2O and O2 by other antioxidant
enzymatic systems. All three existing isoforms of SOD
(SOD1, 2, 3) incorporate a transition metal in their active
site, to catalyse reaction of dismutation: SOD1 and SOD3
require Cu–Zn as a cofactor, whereas SOD2—Mn. SOD
isoforms differ in their cellular location as well: SOD1 is
located in cytosol and mitochondrial intermembrane space,
SOD2 is found in mitochondrial matrix, and SOD3 acts in
extracellular space (Powers et al. 2011; Trachootham et al.
2008). SOD2 was found to reduce ROS in resting muscle
cells (Vasilaki et al. 2006a), SOD1 deficiency is associated
with marked increase in oxidative stress in skeletal muscle
(Muller et al. 2006), whereas contraction of myogenic fibre
involves activation of SOD1 and SOD2 (Powers et al.
1994). Furthermore, SOD activity is elevated in oxidised
myofibres, characterised by high mitochondrial volume
(Powers et al. 1994).
Catalase (CAT) is a heme-dependent enzyme, localized
in peroxisomes, which catalyses breakdown of H2O2 to
H2O and O2 with an extremely high turnover rate—6
million H2O2 molecules/min (Powers et al. 2011; Tra-
chootham et al. 2008). Similarly to SOD, its expression is
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increased in highly oxidised muscle fibres (Powers
et al. 1994).
Glutathione peroxidase (GPX), a Se-dependent enzyme,
reduces H2O2 or organic peroxides (ROOH) to H2O or
alcohol (ROH), respectively. Reduced glutathione (GSH) is
used as a donor of H? in this reaction, and is oxidised to
glutathione disulfide (GSSG) (Powers et al. 2011; Tra-
chootham et al. 2008). GPX has lower affinity to its sub-
strate than CAT in high concentrations of H2O2
(Pietarinen-Runtti et al. 2000; Powers et al. 2011). Like
SOD, GPX is induced in muscle during its contracting and
its level is elevated in highly oxidised myofibres (Powers
et al. 1994), though it was also shown to be engaged in
antioxidant response in resting skeletal muscle cells
(Vasilaki et al. 2006a).
Expression of all three major classes of antioxidant
enzymes—SOD, CAT and GPX—is elevated in a ROS-
dependent manner (Kramer and Goodyear 2007; Powers
et al. 2011; Trachootham et al. 2008). Specifically, two
master regulators of cellular response to oxidative stress,
NF-jB and AP-1 transcription factors, can bind among
others to specific sites in the promoter of SOD2 (Gomez-
Cabrera et al. 2005; Hollander et al. 2001; Ji et al. 2004;
Lee et al. 2011; Vasilaki et al. 2006b), GPX (Vasilaki et al.
2006b) and CAT (Vasilaki et al. 2006b; Zhou et al. 2001)
to induce their expression in skeletal muscle cells. ROS
upregulate NF-jB through activation of IjB kinase, which
phosphorylates IjB inhibitor, leading to its dissociation
and, in this manner, to induction of NF-jB (Trachootham
et al. 2008). On the other hand, AP-1 is a dimer composed
of activating and inhibitory subunits which dimerise and
interact together or with other transcription factors
depending on redox milieu (Powers et al. 2011; Tra-
chootham et al. 2008). Therefore ROS are not only the
executors of muscle degeneration, but also actively trigger
cellular response mechanisms, that reduce the injury
(Barbieri and Sestili 2012).
Apart from SOD, CAT and GPX, which are primary
antioxidant enzymes found in mammalian cells, there are
also enzymes which represent second phase of antioxidant
defence in skeletal muscle cells: c-glutamylcysteine syn-
thetase (GCS) and heme oxygenase-1 (HO-1). Although
not involved in direct ROS scavenging, they are responsi-
ble for synthesis of non-enzymatic antioxidants present in
skeletal muscle—GSH by GCS or biliverdin and bilirubin
by HO-1 (Powers et al. 2011). GSH, apart from being a
substrate for GPX, is able to reduce HO and O2
- as well as
to regenerate radical form of other non-enzymatic antiox-
idants (vitamin E and C) to maintain them in active,
reduced state (Powers et al. 2011; Yu 1994). On the other
hand, products of heme metabolism, biliverdin and its
derivate bilirubin, generated by biliverdin reductase, are
also reductants, though bilirubin is considered to be a better
scavenger of free radicals, protecting cells from both per-
oxyl radicals and H2O2 (Baranano et al. 2002; Stocker
2004). In this regard, it is not surprising that GCS (Sen
et al. 1992; Sen 1995) and HO-1 (Essig et al. 1997; Pile-
gaard et al. 2000; Saxena et al. 2010) are elevated in active
skeletal muscle muscles.
NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1)
is an enzyme that binds FAD or FMN as a cofactor and
performs two-electron reduction of quinones to their cor-
responding hydroquinones, using NADPH or NADH as the
hydride donor. Therby, generation of one-electron reduced
semiquinone and various reactive oxygen intermediates, as
a result of redox cycling, is prevented. In addition to its
catalytic role in reduction of quinones, NQO1 can scavenge
superoxide directly, though less effectively than SOD
(Dinkova-Kostova and Talalay 2010; Ma 2013). Notably,
in skeletal muscles NQO1 expression elevates in response
to aerobic exercise (Rodriguez-Bies et al. 2015).
Among ancillary antioxidant enzymes found in skeletal
muscle, there are also the thioredoxin (TRX), glutaredoxin
(GRX) and peroxiredoxin (PRX) systems (Manabe et al.
2014; Powers et al. 2011). TRX is located in cytosol and
mitochondria, where it reduces disulfide proteins and
concomitantly oxidises its two active cysteine residues.
Disulfide bond that is created in enzymatic active centre of
TRX is then reduced by TRX reductase, using electrons
derived from NADPH (Arner and Holmgren 2000; Han-
schmann et al. 2013). Similarly to TRX, GRX acts also in
cytosol and mitochondria, where it reduces protein thiols
during oxidative stress, whereas the oxidized GRX is then
reduced by NADPH via glutathione reductase and GSH
(Fernandes and Holmgren 2004; Hanschmann et al. 2013;
Kalinina et al. 2008). Finally, PRX is a family of cysteine-
dependant peroxidases, that are found in skeletal muscle
cells either in mitochondrium, where they regulate ROS
homeostasis (Lee et al. 2014), or in cytosol, peroxisomes
and nuclei, depending on isoform (Sakellariou et al. 2014).
PRX act as peroxidases, capable of reducing peroxides,
H2O2 and peroxinitrates, using electrons provided by thiols
such as TRX (Hanschmann et al. 2013; Kalinina et al.
2008). Since PRX molar efficacies are, however, lower
than of GPX and CAT, it may play a role in regulation of
H2O2 as a second messenger, in addition to its antioxidant
properties (Powers et al. 2011).
Noteworthy, GCS, HO-1, NQO1, and at least some
enzymes of TRX family, seem to share the same signalling
pathway, governing their expression in response to ROS—
their promoters contain the antioxidant repose elements
(ARE) which is a binding site for Nrf2 (Chan and Kwong
2000; Hanschmann et al. 2013; Itoh et al. 1997; Ma 2013).
Nrf2 is, next to NF-jB and AP-1, a third important tran-
scription factor, which activity is regulated by redox status
(Pattwell and Jackson 2004; Trachootham et al. 2008).
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Under normal conditions Nrf2 is localized in a cytosol,
bound by inhibitor protein—Keap1. In response to oxida-
tive stress, Keap1 is oxidized, and dissociates from Nrf2,
which in turn translocates to nucleus, heterodimerizes with
Maf proteins, and binds to ARE, to induce expression of
ARE-dependant genes (Ma 2013; Powers et al. 2011;
Trachootham et al. 2008). In this manner, transcription of
both GCS (Chan and Kwong 2000; Ding et al. 2008) and
HO-1 (Kang et al. 2015; Sun et al. 2015) is regulated by
ROS-dependent signalling in myogenic cells.
The complex role of oxidative stress
and antioxidant enzymes during skeletal muscle
regeneration after acute injury
The role of ROS and antioxidant enzymes in skeletal
muscles is well confirmed not only during their physio-
logical activity, but also during excessive exercising
(Gomez-Cabrera et al. 2009), muscle fatigue (Powers et al.
2011) or aging-induced muscle wasting (Fulle et al. 2004).
In this review we will focus, however, on the role of
oxidative stress during skeletal muscle regeneration after
injury.
Striated muscle is a stable tissue with a turnover of
myonuclei only 1–2 % every week. However, this process
can by tremendously enhanced after acute injury, resulting
in the remarkable ability for muscle regeneration.
Mechanically crushed muscle, ischemic, injected with
myotoxin or destroyed by freezing, is able to successfully
recover its structure and function within few weeks. To
meet this, a highly coordinated, sequential, but chronically
overlapping phases of muscle degeneration occur, involv-
ing myolysis and inflammation, strictly followed by
regeneration, involving differentiation of muscle satellite
cells (mSC) (Charge and Rudnicki 2004; Karalaki et al.
2009; Tidball 2011).
ROS are indispensable executors and modulators
of degenerative-inflammatory phase during skeletal
muscle regeneration
Muscle fibre degeneration and concomitant acute inflam-
mation begin within the first few hours post injury. Just
after muscle damage, sarcolemma ruptures and myofibers
undergo necrosis, what is reflected by increased plasma
levels of muscle proteins (i.e. creatine kinase, myosin
heavy chain). It is triggered by release of calcium from
sarcoplasmic reticulum, what drives calcium-dependent
proteolysis leading to tissue degeneration (Brzoska et al.
2011; Charge and Rudnicki 2004; Yin et al. 2013). Muscle
necrosis activates resident mast cells, which in turn secrete
cytokines (i.e. IL-1b, IL-6, TNFa) to recruit circulating
inflammatory cells from the surrounding vasculature
(Bentzinger et al. 2013; Brzoska et al. 2011; Pillon et al.
2013).
The first myeloid cells that invade the damaged muscle
are polymorphonuclear leukocytes, mainly neutrophils,
appearing already 1 h post injury and remaining elevated
for at least next 48 h. They promote proinflammatory
environment, necessary for clearance of cell debris, but
also secrete chemokines (i.e. MIP-1a, MCP-1) to induce
migration of monocytes into a site of injury. During first
few days of inflammatory reaction classic Ly6C? mono-
cytes are predominant, expressing proinflammatory
cytokines (i.e. TNFa, IL-1b) and promoting in this way
further recruitment of monocytes, as well as proliferation
of myogenic cells (Bentzinger et al. 2013; Saclier et al.
2013). Once monocytes invade the tissue, they begin dif-
ferentiation into macrophages, which can be analogously
classified into two major subtypes. Proinflammatory and
phagocytic M1 macrophages (arising after exposure to
TNFa, LPS or IFNc, and secreting TNFa, IL-1b, IL-6),
which are initially present in the damaged tissue, are fol-
lowed by a second wave of anti-inflammatory M2 macro-
phages (developing after stimulation with IL-10, and
releasing IL-10, TGF-b, IGF-1). Although these subpopu-
lations are not exclusive and can be present in regenerating
muscle in the same time, they have distinct functions and
localization: M1 macrophages stimulate proliferation of
myogenic cells and interact with them, whereas M2 reduce
cytolytic damage caused by neutrophils and M1 macro-
phages, increase differentiation of myogenic progenitor
cells and growth of myofibres, promote tissue remodelling,
and can be found in close proximity to differentiating
myocytes (Kharraz et al. 2013; Lemos et al. 2015; Novak
and Koh 2013; Saclier et al. 2013).
At these stages of muscle regeneration ROS are mas-
sively generated, predominantly in neutrophils and M2
macrophages, what is essential for phagocytosis to occur
(Barbieri and Sestili 2012; Ji 2007). Although this process
is indispensable for successful muscle restoration, and ROS
generated in proximity of muscle cells activate signalling
pathways relevant to muscle regeneration, when oxidative
stress is exacerbated it can also lead to secondary damage
of previously uninjured fibres (Barbieri and Sestili 2012;
Bentzinger et al. 2013; Powers et al. 2011; Tidball 2011).
Noteworthy, ROS induced signalling, via activation of
MAPK pathway, NFjB and AP-1, directly induces muscle
protective response (Barbieri and Sestili 2012; Jackson
2008; Powers et al. 2011). Enzymatic antioxidant defence
systems are induced by ROS within first days after injury:
expression of SOD2 and GPX is significantly increased in
injured muscle already 12 h after cardiotoxin-mediated
damage, whereas induction of CAT is delayed and peaks
on the 2nd day post-injury (Singh et al. 2014), followed by
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TRX which reaches highest level on day 7 (Vezzoli et al.
2011). What is more, murine myoblasts destroyed by
contraction, induce the secretion of TRX, PRX and GRX. It
suggests, that these proteins, secreted in response to
oxidative stress, may act as myokines, to limit muscle
injury (Manabe et al. 2014).
Not only inflammatory cells can influence level of ROS
formation during muscle regeneration, but also the ROS
produced in skeletal muscle can regulate post-injury
inflammation. Aging-induced redox imbalance was asso-
ciated with aggravated inflammatory reaction after acute
damage (Ghaly and Marsh 2010). Treatment of skeletal
muscle with the non-enzymatic antioxidants (Avci et al.
2012; Myburgh et al. 2012), GPX-mimicking compound
(Gierer et al. 2010) and finally pharmacological stimulation
of SOD2 (Togliatto et al. 2013) or HO-1 (Wilson et al.
2015) decreased inflammation in skeletal muscle after
trauma. That may in turn result in reduced muscle injury
(Gierer et al. 2010; Jazwa et al. 2013; Li et al. 2005;
Myburgh et al. 2012). The mechanism of these effects
could be possibly associated with a decrease in NF-jB
activity, caused by redox imbalance. Accordingly, muscle
specific impairment of NF-jB activity restricted infiltration
of cardiotoxin-injected skeletal muscle with inflammatory
cells (Mourkioti et al. 2006), while lack of Nrf2, accom-
panied by decreased expression of HO-1, TRX-1 and GCS
was related to NF-jB induction, increase in TNFa and IL-
1b expression and, finally, elevated inflammation and
injury after myotrauma (Al-Sawaf et al. 2014; Florczyk
et al. 2014; Ichihara et al. 2010).
Interestingly, opposite effects of antioxidant-deficiency
on inflammation during muscle regeneration were observed
in SOD3-/- mice. SOD3-deficient animals had less pro-
nounced muscle infiltration with leucocytes and macro-
phages (Kim et al. 2007). This might be related to the fact,
that myeloid cells also express antioxidant enzymes to
protect themselves from ROS-induced cell death (Pietari-
nen-Runtti et al. 2000). Therefore it is probable, that sig-
nificant disturbance in redox homeostasis in SOD3-/- mice
could have led to apoptosis of inflammatory cells.
The effect of oxidative stress and antioxidant enzymes
on the macrophage function and M1 and M2 polarisation
during skeletal muscle regeneration has not been investi-
gated yet. There are, however, some indications that ROS
and cell defence enzymes may play a role in these pro-
cesses. ROS activate expression of proinflammatory
cytokines (Chandel et al. 2000) and TLR-initiated pathway
(West et al. 2011) in macrophages, and thereby they are
necessary for proper activity of these cells. Furthermore,
ROS were found to be necessary for M1 development
during diabetes progression, as in NOX-deficient mice M2
were increased along with M1 impairment (Padgett et al.
2015). Accordingly, SOD1 overexpressing animals had
predominantly M2 macrophages in their lungs (He et al.
2013), whereas HO-1 induction can drive the phenotypic
shift to M2 macrophages (Naito et al. 2014). Because of
some contradictory findings from in vitro studies, showing
that scavenge of O2
- does not affect M1, but augments M2
development (Zhang et al. 2013), M1M2 polarisation needs
to be examined also specifically in regenerating skeletal
muscle.
Antioxidant enzymes and ROS play a role
during differentiation of mSC and myoblasts
To successfully complete regeneration of injured muscle,
inflammatory reaction has to be strictly followed by
restoration of cellular architecture in the damaged area.
The essential components of the myogenic repair phase is a
population of mononucleated muscle stem and progenitor
cells, called muscle satellite cells (mSC). Although com-
prise only 2–10 % nuclei in the myofibre, they are pre-
requisite for muscle regeneration. mSC are located in a
specific niche between sarcolemma and basal lamina. They
become activated upon injury, proliferate and then differ-
entiate into myoblasts (muscle progenitor cells), that fuse
with each other to form multinucleated myotubes and,
finally, mature myofibres. At each stage the mSC and
myoblast functions are tightly coordinated by the sequen-
tial expression of muscle regulatory factors (MRFs—basic
helix-loop-helix transcription factors: Myf5, MyoD, myo-
genin, Myf6) (Karalaki et al. 2009; Relaix and Zammit
2012; Yin et al. 2013).
In a steady-state condition, the quiescent mSC are
arrested at the early stages of myogenic program and
express Pax7 transcription factor. They are also mitotically
non-active and therefore characterised by low organelle
content and high fraction of heterochromatin (Montarras
et al. 2013). During muscle injury, cytokines and growth
factors (i.e. HGF, FGFs, IGF-1, TNFa) are released either
from damaged myocytes, or from other cell types (i.e.
neutrophils, macrophages, fibroblasts) (Brzoska et al. 2011;
Karalaki et al. 2009). They activate mSC, which enhance
the expression of Myf5 and/or MyoD, the factors that are
necessary for proliferation and induction of differentiation,
respectively. Activated mSC, called myoblasts, enter pro-
liferative phase allowing the expansion of myogenic pro-
genitors. The expression of Pax7 is downregulated,
whereas cells upregulate myogenin and Myf6, and after-
wards—the expression of surface proteins (i.e. b1-integrin,
caveolin-3, VCAM) to proceed fusion. In the same time
heterodimerization of MRFs with enhancers (i.e. MEF2)
drives the expression of muscle specific genes (i.e. actins,
myosins, troponins), which are essential for proper mor-
phology and function of skeletal muscle (Dumont et al.
2015; Karalaki et al. 2009; Yin et al. 2013). Activated mSC
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are also able to exit cell cycle without induction of dif-
ferentiation and self-renew to restore population of quies-
cent mSC when they delay drop in expression of Myf5 and
maintain Pax7 protein, but lose MyoD. In this manner
constant mSC cell number, with the potential for myogenic
differentiation, is maintained even after multiple rounds of
activation, ensuring life-long regenerative capacity of the
muscle (Relaix and Zammit 2012; Yin et al. 2013).
The role of ROS in myogenic differentiation is complex
due to the wide spectrum of ROS-induced cellular
responses—low levels of ROS modulate signal transduc-
tion pathways while high ones lead to apoptosis or necrosis
(Barbieri and Sestili 2012). For instance, ROS can cause
inhibition of myogenic differentiation (Ardite et al. 2004;
Fulle et al. 2004; Hansen et al. 2007; Sandiford et al. 2014;
Sestili et al. 2009), and this effect cannot be attributed
solely to increased cell death (Sestili et al. 2009). ROS can
increase NF-jB activity in muscle satellite cells and
myoblasts (Ardite et al. 2004; Catani et al. 2004; Zhou
et al. 2001) which in turn causes reduction of MyoD level
(Guttridge et al. 2000), increases cyclin D1 transcription
and cell proliferation (Guttridge et al. 1999), as well as
enhances expression of YY1, transcriptional repressor of
myogenic genes (Wang et al. 2007). That altogether leads
to inhibition of myoblasts’ differentiation (Guttridge et al.
2000). Accordingly, muscle-restricted inhibition of NF-jB
(Mourkioti et al. 2006) or pharmacological suppression of
its activity (Thaloor et al. 1999) enhanced regeneration
after myotrauma. On the other hand, apart from being an
inhibitor of myogenic differentiation, NF-jB was shown
also to be required for myogenesis (Baeza-Raja and
Munoz-Canoves 2004; Conejo et al. 2001). To make the
situation even more complex, beside ROS-induced upreg-
ulation of NF-jB, oxidation of sulfhydryl groups in NF-jB
by ROS may suppress its binding to DNA of target genes
(Trachootham et al. 2008). Therefore ROS-NF-jB axis can
regulate myogenesis both positively and negatively (Bak-
kar and Guttridge 2010; Barbieri and Sestili 2012). Simi-
larly, ROS can also regulate in a dual manner IGF-1
signalling pathway, which enhances myoblasts differenti-
ation and hypertrophy (Barbieri and Sestili 2012). Namely,
ROS can increase phosphorylation of IGF-1 receptor
(Handayaningsih et al. 2011), while decrease IGF-1 tran-
scription (Handayaningsih et al. 2011; Sestili et al. 2009).
Furthermore, expression of PGC-1a, a regulator of mito-
chondrial biogenesis in muscle cells (Choi et al. 2008) is
inhibited by low levels of H2O2, while high levels of H2O2
enhance transcription via AMPK activation (Irrcher et al.
2009). Additionally, elevated ROS induce mitochondrial
swelling and disruption (Sestili et al. 2009). Since proper
function and biogenesis of mitochondria are required for
successful muscle regeneration (Pawlikowska et al. 2006;
Rochard et al. 2000; Wagatsuma et al. 2011), one can
notice that ROS effect on myogenesis is also bifacial in the
context of mitochondria.
Oxidative stress is one of the causes of apoptotic death
of progenitor and mature skeletal muscle cells, since ROS
trigger early events in apoptotic pathway (Barbieri and
Sestili 2012). ROS alter conformation of mitochondrial
pores to enhance the release of pro-apoptotic proteins (for
example cytochrome c) and facilitate activity of MAPKs as
well as transcription factors required for expression of both
pro- and anti-apoptotic genes (Ji 2007; Primeau et al.
2002). Since accumulation of ROS in matrix is restricted
by antioxidant enzymes, mainly SOD2 and GPX, they
directly influence ROS-induced cell death (Ji 2007).
Interestingly, it was shown that muscle progenitor cells
are better protected from consequences of oxidative stress
than their more mature descendants (Fig. 1). Expression of
SOD1, SOD2, CAT and GPX decreases rapidly during first
24 h after the induction of differentiation in vitro (Franco
et al. 1999). This lack of antioxidant defence might be
somehow compensated by increased, at the same time point,
the GCS activity and GSH level (Ardite et al. 2004; Ding
et al. 2008). Nevertheless, after stimulation with H2O2, the
quiescent mSC survive better than the activated ones (Pal-
lafacchina et al. 2010), whereas mSC are more viable than
myoblasts under the same conditions (Urish et al. 2009) and,
finally, the myoblasts show reduced mortality after treat-
ment with O2
- donor in comparison to myotubes (Franco
et al. 1999). This phenomenon correlates with increased
expression of GPX-3 in quiescent mSC (Pallafacchina et al.
2010), enhanced SOD activity together with upregulated
GSH level in muscle progenitors (Urish et al. 2009) as well
as increased expression of SOD1, SOD2, CAT, and GPX in
myoblasts (Franco et al. 1999) in comparison to their more
differentiated descendants. Since high oxidative stress was
shown to reduce in vivo and in vitro regenerative potential
of myogenic progenitors (Ardite et al. 2004; Drowley et al.
2010; Hansen et al. 2007; Lee et al. 2006), it is not surprising
that changes observed in the levels of antioxidant defence
correlate with enhanced regeneration capacity of muscle
progenitor cells after transplantation (Urish et al. 2009) or
ischemic injury (Wilson et al. 2015).
In vivo effect of antioxidant enzymes on muscle
regeneration can be attributed to the increased viability of
myogenic precursors under oxidative stress. Such protec-
tive potential was shown for GPX (El et al. 2012; Lee et al.
2006; Nishida et al. 2007), SOD1 (Suzuki et al. 2004),
HO-1 (Kozakowska et al. 2012; Laumonier et al. 2008;
Wilson et al. 2015), or CAT (Catani et al. 2004).
Accordingly, decreased level of NQO1 in skeletal muscles
of Nrf2-/- aged mice was correlated with enhanced apop-
tosis, although it must be noted, that Nrf2 deficiency was
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accompanied also by decreased expression of CAT, glu-
tathione reductase and GCS (Miller et al. 2012).
Antioxidant enzymes can also affect proliferation of
mSC and myoblasts. Mitotic activity is decreased in muscle
precursors isolated from GPX-1-/- mice (Lee et al. 2006)
and can be upregulated after stimulation of SOD2 in mSC
(Togliatto et al. 2013) or overexpression of HO-1 in
myoblasts (Kozakowska et al. 2012). However, it must be
noted that a certain level of ROS can promote cell divisions
and that CAT, which expression is upregulated on the 2nd
day post-injury, is able to prevent it (Sciancalepore et al.
2012; Singh et al. 2014). Furthermore, pharmacological
stimulation of SOD2 renders mSC mitotically active due to
downregulation of p57, which is a cyclin-dependent kinase
inhibitor (Togliatto et al. 2013). Of importance, a robust
proliferation is necessary to provide sufficient number of
myogenic progenitors at early stages of regeneration, but it
should be subsequently repressed to induce differentiation.
Therefore, when proliferative phase is prolonged, it could
contribute to inhibition of muscle regeneration, as observed
after transplantation of HO-1 overexpressing myoblasts
(Kozakowska et al. 2012).
Final maturation of skeletal muscle cells and tissue
regeneration can by affected by antioxidant enzymes not
only via changes induced in viability and proliferation of
myogenic cells, but also by regulation of differentiation
process per se. Specifically, increased myotube formation
was observed after GPX upregulation (Hidalgo et al. 2014),
whereas the reverse effects are induced in GPX-1-deficient
mice (Lee et al. 2006) and under reduced GSH concen-
tration (Ardite et al. 2004). These effects are at least par-
tially mediated via sustained NF-jB activity, induced by
GSH depletion (Ardite et al. 2004), which may induce
posttranscriptional loss of mRNA for MyoD, whereas
increases expression of cyclin D1 and YY1 and in this
manner—suppress differentiation (Guttridge et al. 1999;
Guttridge et al. 2000; Wang et al. 2007).
An increase in ROS generation observed during myo-
genic differentiation (Ding et al. 2008; Urish et al. 2009;
Won et al. 2012) was associated with a higher expression
of GCS, induced by Nrf2 (Ding, Choi et al. 2008) or
upregulated transcription of PRX-2 mediated by NF-jB
(Won et al. 2012). However, contradictory results were
also reported. Namely, inhibition of GCS impaired myo-
genesis (Ding et al. 2008), while knockdown of PRX-2
enhanced differentiation of myoblasts (Won et al. 2012).
This may be due to compensatory action of other antioxi-

































Fig. 1 Antioxidant enzymes modulate myogenic proliferation and
differentiation. SOD, GPX, HO-1 induce proliferation of mSC and
myoblasts by decreasing ROS or p57. CAT may inhibit myogenic
proliferation, since certain level of ROS is needed to induce it. GPX-1
was shown to augment fusion of myoblasts depending on ROS-
mediated decrease in NF-jB activity. HO-1 impairs final differenti-
ation by decreasing activity of c/EBPd, expression of myomirs and
increasing SDF-1a. Expression of SOD1, 2, 3, CAT and GPX is
downregulated during progression of myogenic differentiation, what
correlates reversely with the level of mortality of different myogenic
populations in oxidative stress conditions. Graphic provided by http://
www.servier.com/Powerpoint-image-bank was used and modified for
preparation of the figure
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PRX family and CAT were all upregulated in response to
PRX-2 inhibition (Won et al. 2012).
Noteworthy, antioxidant enzymes can affect muscle
progenitor cells also in a ROS-independent manner. Phar-
macological stimulation of SOD2 activity led to increased
proliferation caused by SOD2-miR-221/222-dependent
repression of p57 (Togliatto et al. 2013). Overexpression
HO-1 potently inhibited differentiation of myoblasts
(Kozakowska et al. 2012), but this was neither mimicked
by the supplementation of control cells with antioxidant
products of HO-1 nor by antioxidant N-acetylcysteine.
Instead, the inhibition was conveyed by HO-1-derived
carbon monoxide (CO), which impaired binding of c/EBPd
transcription factor to myod promoter. This resulted in
inhibition of MyoD expression and, consequently, in the
blockage of terminal myogenic differentiation. HO-1
inhibited also generation of muscle-specific miRNA
(myomirs): miR-1, miR-206, and miR-133a/b (Koza-
kowska et al. 2012). Noteworthy, when expression of HO-1
was temporally regulated, to be induced only during first
days after ischemic muscle injury, it decreased mortality in
muscle tissue, enhanced myoblast proliferation and inhib-
ited drivers of differentiation, such as myogenin and miR-
206. Switching off HO-1 at later time points improved
myogenic differentiation by upregulating miR-206 and
myogenin (Jazwa et al. 2013). It may be supposed that
temporal overexpression of HO-1 initially promotes myo-
blast proliferation at early phase of regeneration, as sug-
gested by increase in Pax7 accompanied by inhibition of
MyoD and myogenin. Then switching off HO-1 may
accelerate muscle differentiation by downregulating Pax7
and miR-146a, while upregulating miR-206 and myogenin
(Jazwa et al. 2013). Similar results were recently reported
regarding Nrf2, which was shown to induce proliferation
and inhibit differentiation of mSC (Al-Sawaf et al. 2014).
Effect of antioxidant enzymes on processes
accompanying skeletal muscle regeneration:
angiogenesis and fibrosis
Although angiogenesis and fibrosis are not classically
regarded as components of skeletal muscle restoration, they
are in fact tightly correlated events. Since the vast majority
of muscle progenitor cells are localised near blood vessels,
and the more vascularised muscle is, the more mSC are
present, it is not surprising that regeneration of the injured
muscles involves simultaneous tissue revascularisation to
restore blood supply (Bentzinger et al. 2013; Yin et al.
2013). Fibrosis is defined as formation of a connective
tissue scar due to prior activation of fibroblasts and fibro-
adipogenic progenitors during inflammatory phase.
Although fibroblasts are important components of mSC
niche, as they secrete cytokines and growth factors, a
balance between fibrosis and myogensis is necessary to
provide optimal muscle regeneration and recovery of
contractile function. Especially, that major profibrotic
factor, TGF-b, impairs differentiation of mSC (Bentzinger
et al. 2013; Gharaibeh et al. 2012).
The role of antioxidant enzymes in angiogenesis related
to muscle regeneration was studied in a hind limb ischemia
model, where disruption of oxygen supply resulted in
induction of angiogenic response (Silvestre et al. 2013). In
this experimental setting, SOD3 deficiency was shown to
inhibit capillary formation due to increased O2
- production
(Kim et al. 2007), whereas the opposite effect was induced
by SOD3 overexpression (Oshikawa et al. 2010). Accord-
ingly, lack of GPX-1 protein inhibited blood flow restora-
tion (Galasso et al. 2006), whereas pharmacological
stimulation of SOD2 induced angiogenesis and in this
manner contributed to increased rate of myogenic regen-
eration (Togliatto et al. 2013). It was also demonstrated
that overexpression of TRX reduces oxidative stress in
ischemic skeletal muscle and improves NO bioaviabilty,
thereby inducing angiogenesis (Dai et al. 2009). Although
the level of skeletal muscle regeneration was not estimated,
one can suppose that potent changes in angiogenesis may
promote also myogenesis.
However, the contrary effects of antioxidant enzymes on
angiogenesis were also described. Overexpression of GRX-
1 in skeletal muscle led to increased activity of NFj-B due
to removal of GSH adducts from p65 subunit. That caused
the increased expression of soluble VEGF receptor (sFlt)
and, in consequence, inhibited angiogenesis as well as
function of post-ischemic muscle (Murdoch et al. 2014).
Finally, it is also possible, that the effects of an enzyme
on angiogenesis and myogenesis are opposing. HO-1 was
shown to induce angiogenic response after hind limb
ischemia due to upregulation of proangiogenic growth
factors: SDF-1a and VEGF (Kozakowska et al. 2012;
Kozakowska et al. 2015; Lin et al. 2009; Tongers et al.
2008). Therefore, despite the inhibition of myoblast dif-
ferentiation, potentially exerted also by SDF-1a (Koza-
kowska et al. 2012; Odemis et al. 2007), HO-1 can improve
muscle regeneration after ischemia at least partially due to
increased angiogenesis (Jazwa et al. 2013).
As a final point, antioxidant enzymes are believed to
interfere with the progression of fibrosis in skeletal muscle.
Development of fibrotic tissue during myogenic regenera-
tion was observed in aged animals due to increased TGF-b
expression (Ghaly and Marsh 2010). In aged muscles the
disturbance in redox status and expression of antioxidant
enzymes was also reported (Fulle et al. 2004). Apart from
that, the reverse correlation between total SOD activity and
progression of fibrosis in skeletal muscle was also shown
(Wang et al. 2013). Although HO-1 reduces expression of
TGF-b (Stachurska et al. 2013), and lack of Nrf2 causes
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extensive muscular fibrosis after myotrauma (Al-Sawaf
et al. 2014), the potential antifibrotic effect of HO-1 in
skeletal muscle regeneration was not so far examined.
Oxidative stress in Duchenne muscular dystrophy
The muscular dystrophies comprise more than 30 genetic
syndromes, which are categorized by progressive skeletal
muscle wasting and degeneration. They share common
histological features, including variation in myofibre size,
myofibre degeneration and regeneration, and the replace-
ment of muscle with connective tissue and fat (Manzur and
Muntoni 2009). Elevated ROS level is considered to con-
tribute to the pathology of many muscular dystrophies
(Tidball and Wehling-Henricks 2007). Role of oxidative
stress in the progression of Duchenne muscular dystrophy
(DMD) has been widely recognised and is discussed below.
Oxidative stress is also involved in progression of other
dystrophies and myopathies, but it has been described in
detail elsewhere (Arbogast et al. 2009; Dowling et al. 2012;
Terrill et al. 2013).
DMD is a lethal X–chromosome-linked recessive mus-
cle disease, and is the most severe of progressive muscular
dystrophies. The symptoms of DMD involve a broad and
not easily related set of deficiencies that includes skeletal
muscle weakness, inflammation, wasting and fibrosis,
increased fatigability, cardiomyopathy, lower IQ, muscle
metabolic defects, and synaptic dysfunction (Emery 1989;
Finsterer and Stollberger 2003; Frascarelli et al. 1988;
Tidball and Wehling-Henricks 2004). Despite the broad,
systemic pathophysiology of DMD, the primary cause of
the disease are mutations in the dystrophin gene (Koenig
et al. 1989), which results in deficiency of function of the
membrane-associated protein dystrophin (Emery 2002;
Hoffman et al. 1988). Some other mutations in the same
gene can generate a mildly defective dystrophin protein,
with a less severe disease, usually with later onset, called
Becker muscular dystrophy (Emery 2002). Skeletal and
cardiac myofibres lacking functional dystrophin have an
increased proneness to sarcolemma damage after muscle
contraction, which leads to myofibre necrosis. This results
in inflammation, myogenesis and new muscle formation to
regenerate the tissue (Lapidos et al. 2004; Petrof et al.
1993; Rando 2001). However, repeated cycles of damage
and inflammation over months and years progress to
replacement of muscle by fat and fibrous connective tis-
sues, with severe loss of muscle function, resulting in
premature death, often due to respiratory or cardiac failure
(Bushby et al. 2010).
Muscle damage and weakness with dystrophin defi-
ciency are proposed to be a consequence of damage repair
cycling mediated via material fatigue injury and
inflammation (Rando 2002; Spencer and Tidball 2001;
Warren et al. 1993). Additionally, elevated oxidative stress
has been suggested as a contributing mechanism in the
muscle damage and weakness in dystrophin deficiency in
humans (Haycock et al. 1996; Rodriguez and Tarnopolsky
2003) and mdx mice (Hauser et al. 1995; Kaczor et al.
2007; Ragusa et al. 1997). Dystrophin deficient myofibers
seem to be more exposed to oxidative stress, as previously
reported (Rando et al. 1998b). However, conditional
expression of the Polycomb group protein Bmi1 in mSC
remarkable improved the muscle function in mdx mice by
upregulation of metallothionein 1 (low molecular weight,
cysteine–rich zinc binding protein). Expression of metal-
lothionein 1 was correlated with defence against oxidative
stress-induced cellular damage, resulting in delayed muscle
wasting through reduction of ROS-induced oxidative stress
(Di Foggia et al. 2014).
Interactions between elevated intracellular calcium level
and inflammation are suggested among the causes of the
prominent oxidative stress. Augmented level of cytosolic
calcium leads to increase in the concentration of mito-
chondrial calcium and this affects ATP synthesis. Higher
oxygen consumption and enhanced electron flow through
the electron transport chain during increased ATP pro-
duction, elevates the ROS content in muscles (Brookes
et al. 2004; Feissner et al. 2009). Moreover, membrane
damage during DMD progression stimulates degranulation
of muscle resident mast cells as well as activation of
immune cell cascade (Han 2011; Radley and Grounds
2006). Immune cells, like neutrophils and macrophages,
additionally produce ROS to promote phagocytosis.
Therefore, inflammatory cells, mitochondria, NOX and
decoupling of NOS are the potential sources of producers
of ROS in dystrophin deficiency (Spurney et al. 2008;
Whitehead et al. 2008; Williams and Allen 2007). How-
ever, NAD(P)H oxidase is proposed to be the most sig-
nificant source of oxidative stress and contributor to
dystrophin-associated pathology in muscles. Nox2 may be
activated in response to stretch in dystrophin deficient
muscles, next Nox2-dependent ROS production enhance
Ca2? influx and generation of reactive oxygen species in
mdx mice. Additionally, activated Src kinase leads to fur-
ther activation of Nox2 via p47phox phosphorylation (Pal
et al. 2014).
Antioxidant enzymes in DMD
The possibility that oxidative stress contributes to muscle
pathology in DMD was first proposed by Binder et al.
(Binder et al. 1965), who noted the similarities to muscle
pathology that occurred in vitamin E deficiency, which
directly increases free radicals and oxidative damage. Next,
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Mendell and coworkers (Mendell et al. 1971) suggested
that ischemia–reperfusion muscle injury produces oxida-
tive lesions and damage with pathological characteristics,
which were argued similar to those found in patients with
dystrophinopathies.
Oxidative stress can be an important regulator of DMD
progression. Expression of most of the enzymes associated
with antioxidant defence is augmented in DMD, as well as
in mdx mice (Disatnik et al. 1998; Kar and Pearson 1979;
Matsumura et al. 2013; Ragusa et al. 1997; Rando et al.
1998b). Increased levels of lipid and protein oxidation also
have been reported in animal models of muscular dystro-
phy (Disatnik et al. 1998; Hauser et al. 1995) and in dys-
trophic muscles of patients with DMD (Haycock et al.
1996; Kar and Pearson 1979; Mechler et al. 1984), and
correlated in part with the degree of histopathological
alterations (Ragusa et al. 1997).
SOD1 expression is significantly increased in dystrophin
deficient muscles. However, due its activity is connected
with conversion of superoxide to hydrogen peroxide, which
can participate in lipid peroxidation, the increase in SOD1
may have a detrimental rather than protective role in DMD.
Muscular overexpression of SOD1 enhanced of lipid per-
oxidation in the muscles and elevated muscle cytosolic
proteins in serum (Rando et al. 1998a). In turn, delivery to
mice the catalytic mimetic of SOD and CAT (EUK-134),
which eliminate both O2
- and H2O2, reduced markers of
oxidative stress in the mdx diaphragm. This was accom-
panied with decreased macrophages and T-cells infiltration
as well as improved markers of muscle damage (Kim and
Lawler 2012). The overexpression of CAT by AAV gene
transfer improved functions of skeletal muscles in mdx
mice (Selsby 2011).
One of the important antioxidant pathways is the glu-
tathione system, essential in protection against the harmful
effects of ROS and oxidative stress (Bast et al. 1991).
Oxidative damage in DMD was attributed to the decreased
level of GSH due to lowered activity of gamma-glutamyl
cysteine ligase, the rate limiting enzyme in GSH synthesis
(Renjini et al. 2012). Additionally, larger activity of GSH
metabolizing enzymes, GPX and glutathione reductase,
with concomitantly increased GSSG:GSH ratio indicated
the acute oxidative stress in the hind limb muscles of mdx
mice (Dudley et al. 2006).
Muscle damage, inflammation and oxidative stress can
activate NF-jB through phosphorylation and release of the
inhibitor protein I-jB (inhibitory jB) (Gius et al. 1999).
ROS can regulate NF-jB via multiple mechanisms, and
ROS induced NF-jB activation has been well described
(Whitehead et al. 2006). On the other hand, NF-jB is an
important mediator of redox-responsive gene expression
and actively involved in the upregulation of antioxidant
enzymes, such as GPX and CAT, in response to oxidative
stress (Zhou et al. 2001). Moreover, activated NF-jB
amplifies the release of ROS and proinflammatory proteins
(such as TNF-a and IL-1b), and its activity has been shown
to be higher in the diaphragm and limb muscle of mdx mice
compared with wild-type mice (Kumar and Boriek 2003;
Rajakumar et al. 2013). Glucocorticoid therapy moderated
high levels of NF-jB and oxidative stress, concomitant
with reduced muscle damage and enhanced functional
properties (Lim et al. 2004; Messina et al. 2009). Recently
inhibition of NF-jB using peptide containing the NF-jB
essential modulator binding domain resulted in decreased
necrosis and improved regeneration in muscles of mdx
mice (Reay et al. 2011). Moreover IRFI-042, an inhibitor
of lipid peroxidation, reduced NF-jB activation and cell
necrosis (Messina et al. 2006).
Additionally, role of enzymes representing second phase
of antioxidant protection has been investigated. HO-1
expression was detected to be upregulated in diaphragm of
mdx muscles. However it was mainly localized rather in
macrophages infiltrating injured muscle than in muscle
fibres (Hnia et al. 2007). Reduced level of HO-1 in Stra13-
deficient mdx mice resulted in accelerated muscle damage
as an effect of increased oxidative stress due to ROS pro-
duction (Vercherat et al. 2009). The hypothesis that HO-1
could be a potential therapeutic target for DMD, is sup-
ported by studies, where sulforaphane treatment of mdx
mice activated in skeletal muscles the HO-1 expression in
Nrf2 dependent way, what resulted in reduction of infil-
tration of immune cells and expression of the inflammatory
cytokines (TNF-a, IL-1b and IL-6) (Sun et al. 2015).
All together this suggests, that oxidative stress may act
upstream of proinflammatory signalling in mdx mice and
antioxidant treatments could be used in therapy to avoid or
postpone muscle wasting in DMD. Prevention of pathology
in dystrophin deficient mice by application of different
antioxidants has been recently intensively investigated and
reviewed (Hnia et al. 2008; Kim et al. 2013; Kim and
Lawler 2012; Messina et al. 2009; Nakae et al. 2012;
Whitehead et al. 2008). The favourable effects in modu-
lating the oxidative stress were also achieved by low-level
laser therapy which decreased ROS and increased activity
of antioxidant enzymes such as SOD, CAT and GPX (Leal
Junior et al. 2010; Macedo et al. 2015). Additionally, the
low-intensity endurance exercise has beneficial influence
on skeletal muscle of mdx mice. Its application decreased
protein carbonyls in mdx muscles and reduced oxidative
stress markers (Kaczor et al. 2007). Furthermore, in mdx
mice after low-intensity training the level of carbonic
anhydrase 3 and SOD1 was completely restored, what may
suggest that this kind of treatment may counteract oxida-
tive stress (Fontana et al. 2015).
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Conclusions
Evidences presented here suggest, that oxidative stress is
an important modulator of skeletal muscle regeneration
after injury. A delicate balance between ROS production
and antioxidant enzymes expression and activity plays
significant role in maintaining muscle homeostasis. In the
first phase of skeletal muscle regeneration ROS are crucial
players in induction of removal of necrotic muscle fibres
and attenuating muscle injury. Later, the antioxidant
enzymes as well as ROS can also affect proliferation,
differentiation and final maturation of muscle progenitor
cells. Additionally, the antioxidant enzymes are considered
to take part in regulation of fibrosis of skeletal muscles.
Enhanced oxidative stress is proposed to be the essential
mechanism in the muscle damage and weakness in dys-
trophin deficiency. Upregulated expression of antioxidant
enzymes may be used as a marker of the disease. Preven-
tion of oxidative stress is deliberated as a target for ther-
apeutic treatment in muscular dystrophies. However,
because of the complexity of involvement the oxidative
stress in muscle homeostasis, still many questions need
further investigation to explain exact role of oxidative
stress in muscle regeneration.
Acknowledgments The research onmuscle regeneration is supported
by grants from National Science Centre – MAESTRO - 2012/06/A/
NZ1/00004 (JD), OPUS - 2012/07/B/NZ1/02881 (JD) and Polish
Ministry of Science and Higher Education: Iuventus Plus - IP2012
025572 (MK). MK and KPG are recipients of Ministry of Science and
Higher Education Scholarship. Faculty of Biochemistry, Biophysics
andBiotechnology of JagiellonianUniversity is a partner of theLeading
National Research Centre (KNOW) supported by the Ministry of Sci-
ence and Higher Education.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
Al-Sawaf O, Fragoulis A, Rosen C, Kan YW, Sonmez TT, Pufe T,
Wruck CJ (2014) Nrf2 protects against TWEAK-mediated
skeletal muscle wasting. Sci Rep 4:3625. doi:10.1038/srep03625
Arbogast S, Beuvin M, Fraysse B, Zhou H, Muntoni F, Ferreiro A
(2009) Oxidative stress in SEPN1-related myopathy: from
pathophysiology to treatment. Ann Neurol 65:677–686. doi:10.
1002/ana.21644
Ardite E, Barbera JA, Roca J, Fernandez-Checa JC (2004) Glu-
tathione depletion impairs myogenic differentiation of murine
skeletal muscle C2C12 cells through sustained NF-kappaB
activation. Am J Pathol 165:719–728
Arner ES, Holmgren A (2000) Physiological functions of thioredoxin
and thioredoxin reductase. Eur J Biochem 267:6102–6109
Avci G, Kadioglu H, Sehirli AO, Bozkurt S, Guclu O, Arslan E,
Muratli SK (2012) Curcumin protects against ischemia/reperfu-
sion injury in rat skeletal muscle. J Surg Res 172:e39–e46.
doi:10.1016/j.jss.2011.08.021
Baeza-Raja B, Munoz-Canoves P (2004) p38 MAPK-induced nuclear
factor-kappaB activity is required for skeletal muscle differen-
tiation: role of interleukin-6. Mol Biol Cell 15:2013–2026.
doi:10.1091/mbc.E03-08-0585
Bakkar N, Guttridge DC (2010) NF-kappaB signaling: a tale of two
pathways in skeletal myogenesis. Physiol Rev 90:495–511.
doi:10.1152/physrev.00040.2009
Baranano DE, Rao M, Ferris CD, Snyder SH (2002) Biliverdin
reductase: a major physiologic cytoprotectant. Proc Natl Acad
Sci U S A 99:16093–16098. doi:10.1073/pnas.252626999
Barbieri E, Sestili P (2012) Reactive oxygen species in skeletal
muscle signaling. J Signal Transduct 2012:982794. doi:10.1155/
2012/982794
Bar-Shai M, Carmeli E, Ljubuncic P, Reznick AZ (2008) Exercise
and immobilization in aging animals: the involvement of
oxidative stress and NF-kappaB activation. Free Radic Biol
Med 44:202–214. doi:10.1016/j.freeradbiomed.2007.03.019
Bast A, Haenen GR, Doelman CJ (1991) Oxidants and antioxidants:
state of the art. Am J Med 91:2S–13S
Beckendorf L, Linke WA (2015) Emerging importance of oxidative
stress in regulating striated muscle elasticity. J Muscle Res Cell
Motil 36:25–36. doi:10.1007/s10974-014-9392-y
Bentzinger CF, Wang YX, Dumont NA, Rudnicki MA (2013)
Cellular dynamics in the muscle satellite cell niche. EMBO Rep
14:1062–1072. doi:10.1038/embor.2013.182
Binder HJ, Herting DC, Hurst V, Finch SC, Spiro HM (1965)
Tocopherol deficiency in man. N Engl J Med 273:1289–1297.
doi:10.1056/NEJM196512092732401
Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS (2004)
Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am
J Physiol Cell Physiol 287:C817–C833. doi:10.1152/ajpcell.
00139.2004
Brzoska E, Ciemerych MA, Przewozniak M, Zimowska M (2011)
Regulation of muscle stem cells activation: the role of growth
factors and extracellular matrix. Vitam Horm 87:239–276.
doi:10.1016/B978-0-12-386015-6.00031-7
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L,
Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F,
Tomezsko J, Constantin C (2010) Diagnosis and management of
Duchenne muscular dystrophy, part 1: diagnosis, and pharma-
cological and psychosocial management. Lancet Neurol
9:77–93. doi:10.1016/S1474-4422(09)70271-6
Catani MV, Savini I, Duranti G, Caporossi D, Ceci R, Sabatini S,
Avigliano L (2004) Nuclear factor kappaB and activating protein
1 are involved in differentiation-related resistance to oxidative
stress in skeletal muscle cells. Free Radic Biol Med
37:1024–1036. doi:10.1016/j.freeradbiomed.2004.06.021
Chan JY, Kwong M (2000) Impaired expression of glutathione
synthetic enzyme genes in mice with targeted deletion of the
Nrf2 basic-leucine zipper protein. Biochim Biophys Acta
1517:19–26
Chandel NS, Trzyna WC, McClintock DS, Schumacker PT (2000)
Role of oxidants in NF-kappa B activation and TNF-alpha gene
transcription induced by hypoxia and endotoxin. J Immunol
165:1013–1021
Charge SB, Rudnicki MA (2004) Cellular and molecular regulation of
muscle regeneration. Physiol Rev 84:209–238. doi:10.1152/
physrev.00019.2003
Choi CS, Befroy DE, Codella R, Kim S, Reznick RM, Hwang YJ, Liu
ZX, Lee HY, Distefano A, Samuel VT, Zhang D, Cline GW,
Handschin C, Lin J, Petersen KF, Spiegelman BM, Shulman GI
(2008) Paradoxical effects of increased expression of PGC-
J Muscle Res Cell Motil (2015) 36:377–393 387
123
1alpha on muscle mitochondrial function and insulin-stimulated
muscle glucose metabolism. Proc Natl Acad Sci U S A
105:19926–19931. doi:10.1073/pnas.0810339105
Conejo R, Valverde AM, Benito M, Lorenzo M (2001) Insulin produces
myogenesis in C2C12 myoblasts by induction of NF-kappaB and
downregulation of AP-1 activities. J Cell Physiol 186:82–94. doi:10.
1002/1097-4652(200101)186:1\82:AID-JCP1001[3.0.CO;2-R
Dai S, He Y, Zhang H, Yu L, Wan T, Xu Z, Jones D, Chen H, Min W
(2009) Endothelial-specific expression of mitochondrial thiore-
doxin promotes ischemia-mediated arteriogenesis and angiogen-
esis. Arterioscler Thromb Vasc Biol 29:495–502. doi:10.1161/
ATVBAHA.108.180349
Di Foggia V, Zhang X, Licastro D, Gerli MF, Phadke R, Muntoni F,
Mourikis P, Tajbakhsh S, Ellis M, Greaves LC, Taylor RW,
Cossu G, Robson LG, Marino S (2014) Bmi1 enhances skeletal
muscle regeneration through MT1-mediated oxidative stress
protection in a mouse model of dystrophinopathy. J Exp Med
211:2617–2633. doi:10.1084/jem.20140317
Ding Y, Choi KJ, Kim JH, Han X, Piao Y, Jeong JH, Choe W, Kang I,
Ha J, Forman HJ, Lee J, Yoon KS, Kim SS (2008) Endogenous
hydrogen peroxide regulates glutathione redox via nuclear factor
erythroid 2-related factor 2 downstream of phosphatidylinositol
3-kinase during muscle differentiation. Am J Pathol
172:1529–1541. doi:10.2353/ajpath.2008.070429
Dinkova-Kostova AT, Talalay P (2010) NAD(P)H:quinone acceptor
oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme
and exceptionally versatile cytoprotector. Arch Biochem Bio-
phys 501:116–123. doi:10.1016/j.abb.2010.03.019
Disatnik MH, Dhawan J, Yu Y, Beal MF, Whirl MM, Franco AA,
Rando TA (1998) Evidence of oxidative stress in mdx mouse
muscle: studies of the pre-necrotic state. J Neurol Sci 161:77–84
Dowling JJ, Arbogast S, Hur J, Nelson DD, McEvoy A, Waugh T,
Marty I, Lunardi J, Brooks SV, Kuwada JY, Ferreiro A (2012)
Oxidative stress and successful antioxidant treatment in models
of RYR1-related myopathy. Brain 135:1115–1127. doi:10.1093/
brain/aws036
Droge W (2002) Free radicals in the physiological control of cell
function. Physiol Rev 82:47–95. doi:10.1152/physrev.00018.
2001
Drowley L, Okada M, Beckman S, Vella J, Keller B, Tobita K, Huard
J (2010) Cellular antioxidant levels influence muscle stem cell
therapy. Mol Ther 18:1865–1873. doi:10.1038/mt.2010.160
Dudley RW, Khairallah M, Mohammed S, Lands L, Des RC, Petrof
BJ (2006) Dynamic responses of the glutathione system to acute
oxidative stress in dystrophic mouse (mdx) muscles. Am J
Physiol Regul Integr Comp Physiol 291:R704–R710. doi:10.
1152/ajpregu.00031.2006
Dumont NA, Wang YX, Rudnicki MA (2015) Intrinsic and extrinsic
mechanisms regulating satellite cell function. Development
142:1572–1581. doi:10.1242/dev.114223
El HM, Jean E, Turki A, Hugon G, Vernus B, Bonnieu A, Passerieux
E, Hamade A, Mercier J, Laoudj-Chenivesse D, Carnac G (2012)
Glutathione peroxidase 3, a new retinoid target gene, is crucial
for human skeletal muscle precursor cell survival. J Cell Sci
125:6147–6156. doi:10.1242/jcs.115220
Emery AE (1989) Clinical and molecular studies in Duchenne
muscular dystrophy. Prog Clin Biol Res 306:15–28
Emery AE (2002) The muscular dystrophies. Lancet 359:687–695.
doi:10.1016/S0140-6736(02)07815-7
Essig DA, Borger DR, Jackson DA (1997) Induction of heme
oxygenase-1 (HSP32) mRNA in skeletal muscle following
contractions. Am J Physiol 272:C59–C67
Feissner RF, Skalska J, Gaum WE, Sheu SS (2009) Crosstalk
signaling between mitochondrial Ca2? and ROS. Front Biosci
(Landmark Ed) 14:1197–1218
Fernandes AP, Holmgren A (2004) Glutaredoxins: glutathione-
dependent redox enzymes with functions far beyond a simple
thioredoxin backup system. Antioxid Redox Signal 6:63–74.
doi:10.1089/152308604771978354
Finsterer J, Stollberger C (2003) The heart in human dys-
trophinopathies. Cardiology 99:1–19
Florczyk U, Jazwa A, Maleszewska M, Mendel M, Szade K,
Kozakowska M, Grochot-Przeczek A, Viscardi M, Czauderna
S, Bukowska-Strakova K, Kotlinowski J, Jozkowicz A, Loboda
A, Dulak J (2014) Nrf2 regulates angiogenesis: effect on
endothelial cells, bone marrow-derived proangiogenic cells and
hind limb ischemia. Antioxid Redox Signal 20:1693–1708.
doi:10.1089/ars.2013.5219
Fontana S, Schillaci O, Frinchi M, Giallombardo M, Morici G, Di
Liberto V, Alessandro R, De Leo G, Perciavalle V, Belluardo N,
Mudo’ G (2015) Reduction of mdx mouse muscle degeneration
by low-intensity endurance exercise: a proteomic analysis in
quadriceps muscle of exercised versus sedentary mdx mice.
Biosci Rep. doi:10.1042/BSR20150013
Franco AA, Odom RS, Rando TA (1999) Regulation of antioxidant
enzyme gene expression in response to oxidative stress and
during differentiation of mouse skeletal muscle. Free Radic Biol
Med 27:1122–1132
Frascarelli M, Rocchi L, Feola I (1988) EMG computerized analysis
of localized fatigue in Duchenne muscular dystrophy. Muscle
Nerve 11:757–761. doi:10.1002/mus.880110712
Fulle S, Protasi F, di Tano G, Pietrangelo T, Beltramin A,
Boncompagni S, Vecchiet L, Fano G (2004) The contribution
of reactive oxygen species to sarcopenia and muscle ageing. Exp
Gerontol 39:17–24
Galasso G, Schiekofer S, Sato K, Shibata R, Handy DE, Ouchi N,
Leopold JA, Loscalzo J, Walsh K (2006) Impaired angiogenesis
in glutathione peroxidase-1-deficient mice is associated with
endothelial progenitor cell dysfunction. Circ Res 98:254–261.
doi:10.1161/01.RES.0000200740.57764.52
Ghaly A, Marsh DR (2010) Aging-associated oxidative stress
modulates the acute inflammatory response in skeletal muscle
after contusion injury. Exp Gerontol 45:381–388. doi:10.1016/j.
exger.2010.03.004
Gharaibeh B, Chun-Lansinger Y, Hagen T, Ingham SJ, Wright V, Fu
F, Huard J (2012) Biological approaches to improve skeletal
muscle healing after injury and disease. Birth Defects Res C
Embryo Today 96:82–94. doi:10.1002/bdrc.21005
Gierer P, Rother J, Mittlmeier T, Gradl G, Vollmar B (2010) Ebselen
reduces inflammation and microvascular perfusion failure after
blunt skeletal muscle injury of the rat. J Trauma 68:853–858.
doi:10.1097/TA.0b013e3181b28a18
Gius D, Botero A, Shah S, Curry HA (1999) Intracellular oxidation/
reduction status in the regulation of transcription factors NF-
kappaB and AP-1. Toxicol Lett 106:93–106
Gomez-Cabrera MC, Borras C, Pallardo FV, Sastre J, Ji LL, Vina J
(2005) Decreasing xanthine oxidase-mediated oxidative stress
prevents useful cellular adaptations to exercise in rats. J Physiol
567:113–120. doi:10.1113/jphysiol.2004.080564
Gomez-Cabrera MC, Vina J, Ji LL (2009) Interplay of oxidants and
antioxidants during exercise: implications for muscle health.
Phys Sportsmed 37:116–123. doi:10.3810/psm.2009.12.1749
Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr
(1999) NF-kappaB controls cell growth and differentiation
through transcriptional regulation of cyclin D1. Mol Cell Biol
19:5785–5799
Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr
(2000) NF-kappaB-induced loss of MyoD messenger RNA:
possible role in muscle decay and cachexia. Science
289:2363–2366
388 J Muscle Res Cell Motil (2015) 36:377–393
123
Han R (2011) Muscle membrane repair and inflammatory attack in
dysferlinopathy. Skelet Muscle 1:10. doi:10.1186/2044-5040-1-10
Handayaningsih AE, Iguchi G, Fukuoka H, Nishizawa H, Takahashi
M, Yamamoto M, Herningtyas EH, Okimura Y, Kaji H, Chihara
K, Seino S, Takahashi Y (2011) Reactive oxygen species play an
essential role in IGF-I signaling and IGF-I-induced myocyte
hypertrophy in C2C12 myocytes. Endocrinology 152:912–921.
doi:10.1210/en.2010-0981
Hanschmann EM, Godoy JR, Berndt C, Hudemann C, Lillig CH
(2013) Thioredoxins, glutaredoxins, and peroxiredoxins–molec-
ular mechanisms and health significance: from cofactors to
antioxidants to redox signaling. Antioxid Redox Signal
19:1539–1605. doi:10.1089/ars.2012.4599
Hansen JM, Klass M, Harris C, Csete M (2007) A reducing redox
environment promotes C2C12 myogenesis: implications for
regeneration in aged muscle. Cell Biol Int 31:546–553. doi:10.
1016/j.cellbi.2006.11.027
Hauser E, Hoger H, Bittner R, Widhalm K, Herkner K, Lubec G
(1995) Oxyradical damage and mitochondrial enzyme activities
in the mdx mouse. Neuropediatrics 26:260–262. doi:10.1055/s-
2007-979768
Haycock JW, MacNeil S, Jones P, Harris JB, Mantle D (1996)
Oxidative damage to muscle protein in Duchenne muscular
dystrophy. NeuroReport 8:357–361
He C, Ryan AJ, Murthy S, Carter AB (2013) Accelerated develop-
ment of pulmonary fibrosis via Cu, Zn-superoxide dismutase-
induced alternative activation of macrophages. J Biol Chem
288:20745–20757. doi:10.1074/jbc.M112.410720
Hidalgo M, Marchant D, Quidu P, Youcef-Ali K, Richalet JP,
Beaudry M, Besse S, Launay T (2014) Oxygen modulates the
glutathione peroxidase activity during the L6 myoblast early
differentiation process. Cell Physiol Biochem 33:67–77. doi:10.
1159/000356650
Hnia K, Hugon G, Rivier F, Masmoudi A, Mercier J, Mornet D (2007)
Modulation of p38 mitogen-activated protein kinase cascade and
metalloproteinase activity in diaphragm muscle in response to
free radical scavenger administration in dystrophin-deficient
Mdx mice. Am J Pathol 170:633–643. doi:10.2353/ajpath.2007.
060344
Hnia K, Gayraud J, Hugon G, Ramonatxo M, De La Porte S, Matecki
S, Mornet D (2008) L-arginine decreases inflammation and
modulates the nuclear factor-kappaB/matrix metalloproteinase
cascade in mdx muscle fibers. Am J Pathol 172:1509–1519.
doi:10.2353/ajpath.2008.071009
Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loike
JD, Harris JB, Waterston R, Brooke M, Specht L (1988)
Characterization of dystrophin in muscle-biopsy specimens from
patients with Duchenne’s or Becker’s muscular dystrophy. N Engl
J Med 318:1363–1368. doi:10.1056/NEJM198805263182104
Hollander J, Fiebig R, Gore M, Ookawara T, Ohno H, Ji LL (2001)
Superoxide dismutase gene expression is activated by a single
bout of exercise in rat skeletal muscle. Pflugers Arch
442:426–434
Ichihara S, Yamada Y, Liu F, Murohara T, Itoh K, Yamamoto M,
Ichihara G (2010) Ablation of the transcription factor Nrf2
promotes ischemia-induced neovascularization by enhancing the
inflammatory response. Arterioscler Thromb Vasc Biol
30:1553–1561. doi:10.1161/ATVBAHA.110.204123
Irrcher I, Ljubicic V, Hood DA (2009) Interactions between ROS and
AMP kinase activity in the regulation of PGC-1alpha transcrip-
tion in skeletal muscle cells. Am J Physiol Cell Physiol
296:C116–C123. doi:10.1152/ajpcell.00267.2007
Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T,
Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y
(1997) An Nrf2/small Maf heterodimer mediates the induction of
phase II detoxifying enzyme genes through antioxidant response
elements. Biochem Biophys Res Commun 236:313–322
Jackson MJ (2008) Free radicals generated by contracting muscle: by-
products of metabolism or key regulators of muscle function?
Free Radic Biol Med 44:132–141. doi:10.1016/j.freeradbiomed.
2007.06.003
Jazwa A, Stepniewski J, Zamykal M, Jagodzinska J, Meloni M,
Emanueli C, Jozkowicz A, Dulak J (2013) Pre-emptive hypoxia-
regulated HO-1 gene therapy improves post-ischaemic limb
perfusion and tissue regeneration in mice. Cardiovasc Res
97:115–124. doi:10.1093/cvr/cvs284
Ji LL (2007) Antioxidant signaling in skeletal muscle: a brief review.
Exp Gerontol 42:582–593. doi:10.1016/j.exger.2007.03.002
Ji LL, Gomez-Cabrera MC, Steinhafel N, Vina J (2004) Acute
exercise activates nuclear factor (NF)-kappaB signaling pathway
in rat skeletal muscle. FASEB J 18:1499–1506. doi:10.1096/fj.
04-1846com
Kaczor JJ, Hall JE, Payne E, Tarnopolsky MA (2007) Low intensity
training decreases markers of oxidative stress in skeletal muscle
of mdx mice. Free Radic Biol Med 43:145–154. doi:10.1016/j.
freeradbiomed.2007.04.003
Kalinina EV, Chernov NN, Saprin AN (2008) Involvement of thio-,
peroxi-, and glutaredoxins in cellular redox-dependent processes.
Biochemistry (Mosc) 73:1493–1510
Kang JS, Choi IW, Han MH, Hong SH, Kim SO, Kim GY, Hwang
HJ, Kim BW, Choi BT, Kim CM, Choi YH (2015) Sargassum
horneri methanol extract rescues C2C12 murine skeletal muscle
cells from oxidative stress-induced cytotoxicity through Nrf2-
mediated upregulation of heme oxygenase-1. BMC Complement
Altern Med 15:17. doi:10.1186/s12906-015-0538-2
Kar NC, Pearson CM (1979) Catalase, superoxide dismutase,
glutathione reductase and thiobarbituric acid-reactive products
in normal and dystrophic human muscle. Clin Chim Acta
94:277–280
Karalaki M, Fili S, Philippou A, Koutsilieris M (2009) Muscle
regeneration: cellular and molecular events. In Vivo 23:779–796
Kharraz Y, Guerra J, Mann CJ, Serrano AL, Munoz-Canoves P
(2013) Macrophage plasticity and the role of inflammation in
skeletal muscle repair. Mediators Inflamm 2013:491497. doi:10.
1155/2013/491497
Kim JH, Lawler JM (2012) Amplification of proinflammatory
phenotype, damage, and weakness by oxidative stress in the
diaphragm muscle of mdx mice. Free Radic Biol Med
52:1597–1606. doi:10.1016/j.freeradbiomed.2012.01.015
Kim HW, Lin A, Guldberg RE, Ushio-Fukai M, Fukai T (2007)
Essential role of extracellular SOD in reparative neovascular-
ization induced by hindlimb ischemia. Circ Res 101:409–419.
doi:10.1161/CIRCRESAHA.107.153791
Kim JH, Kwak HB, Thompson LV, Lawler JM (2013) Contribution of
oxidative stress to pathology in diaphragm and limb muscles
with Duchenne muscular dystrophy. J Muscle Res Cell Motil
34:1–13. doi:10.1007/s10974-012-9330-9
Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken
T, Meng G, Muller CR, Lindlof M, Kaariainen H (1989) The
molecular basis for Duchenne versus Becker muscular dystro-
phy: correlation of severity with type of deletion. Am J Hum
Genet 45:498–506
Kozakowska M, Ciesla M, Stefanska A, Skrzypek K, Was H, Jazwa
A, Grochot-Przeczek A, Kotlinowski J, Szymula A, Bartelik A,
Mazan M, Yagensky O, Florczyk U, Lemke K, Zebzda A,
Dyduch G, Nowak W, Szade K, Stepniewski J, Majka M,
Derlacz R, Loboda A, Dulak J, Jozkowicz A (2012) Heme
oxygenase-1 inhibits myoblast differentiation by targeting
myomirs. Antioxid Redox Signal 16:113–127. doi:10.1089/ars.
2011.3964
J Muscle Res Cell Motil (2015) 36:377–393 389
123
Kozakowska M, Kotlinowski J, Grochot-Przeczek A, Ciesla M,
Pilecki B, Derlacz R, Dulak J, Jozkowicz A (2015) Myoblast-
conditioned media improve regeneration and revascularization
of ischemic muscles in diabetic mice. Stem Cell Res Ther 6:61.
doi:10.1186/s13287-015-0063-8
Kramer HF, Goodyear LJ (2007) Exercise, MAPK, and NF-kappaB
signaling in skeletal muscle. J Appl Physiol 103:388–395.
doi:10.1152/japplphysiol.00085.2007
Kumar A, Boriek AM (2003) Mechanical stress activates the nuclear
factor-kappaB pathway in skeletal muscle fibers: a possible role
in Duchenne muscular dystrophy. FASEB J 17:386–396. doi:10.
1096/fj.02-0542com
Lamb GD, Westerblad H (2011) Acute effects of reactive oxygen and
nitrogen species on the contractile function of skeletal muscle.
J Physiol 589:2119–2127. doi:10.1113/jphysiol.2010.199059
Lapidos KA, Kakkar R, McNally EM (2004) The dystrophin
glycoprotein complex: signaling strength and integrity for the
sarcolemma. Circ Res 94:1023–1031. doi:10.1161/01.RES.
0000126574.61061.25
Laumonier T, Yang S, Konig S, Chauveau C, Anegon I, Hoffmeyer P,
Menetrey J (2008) Lentivirus mediated HO-1 gene transfer
enhances myogenic precursor cell survival after autologous
transplantation in pig. Mol Ther 16:404–410. doi:10.1038/sj.mt.
6300354
Leal Junior EC, Lopes-Martins RA, de Almeida P, Ramos L, Iversen
VV, Bjordal JM (2010) Effect of low-level laser therapy (GaAs
904 nm) in skeletal muscle fatigue and biochemical markers of
muscle damage in rats. Eur J Appl Physiol 108:1083–1088.
doi:10.1007/s00421-009-1321-1
Lee S, Shin HS, Shireman PK, Vasilaki A, Van RH, Csete ME (2006)
Glutathione-peroxidase-1 null muscle progenitor cells are glob-
ally defective. Free Radic Biol Med 41:1174–1184. doi:10.1016/
j.freeradbiomed.2006.07.005
Lee S, Tak E, Lee J, Rashid MA, Murphy MP, Ha J, Kim SS (2011)
Mitochondrial H2O2 generated from electron transport chain
complex I stimulates muscle differentiation. Cell Res
21:817–834. doi:10.1038/cr.2011.55
LeeKP,ShinYJ,ChoSC,LeeSM,BahnYJ,KimJY,KwonES, do Jeong
Y, Park SC, Rhee SG, Woo HA, Kwon KS (2014) Peroxiredoxin 3
has a crucial role in the contractile function of skeletal muscle by
regulating mitochondrial homeostasis. Free Radic Biol Med
77:298–306. doi:10.1016/j.freeradbiomed.2014.09.010
Lemos DR, Babaeijandaghi F, Low M, Chang CK, Lee ST, Fiore D,
Zhang RH, Natarajan A, Nedospasov SA, Rossi FM (2015)
Nilotinib reduces muscle fibrosis in chronic muscle injury by
promoting TNF-mediated apoptosis of fibro/adipogenic progen-
itors. Nat Med 21:786–794. doi:10.1038/nm.3869
Li G, Feng X, Wang S (2005) Effects of Cu/Zn superoxide dismutase
on strain injury-induced oxidative damage to skeletal muscle in
rats. Physiol Res 54:193–199
Lim JH, Kim DY, Bang MS (2004) Effects of exercise and steroid on
skeletal muscle apoptosis in the mdx mouse. Muscle Nerve
30:456–462. doi:10.1002/mus.20139
Lin HH, Chen YH, Yet SF, Chau LY (2009) After vascular injury,
heme oxygenase-1/carbon monoxide enhances re-endothelial-
ization via promoting mobilization of circulating endothelial
progenitor cells. J Thromb Haemost 7:1401–1408. doi:10.1111/j.
1538-7836.2009.03478.x
Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev
Pharmacol Toxicol 53:401–426. doi:10.1146/annurev-pharmtox-
011112-140320
MacedoAB,Moraes LH,Mizobuti DS, FogacaAR,Moraes FD, Hermes
TA, PertilleA,Minatel E (2015) Low-Level Laser Therapy (LLLT)
in Dystrophin-Deficient Muscle Cells: effects on Regeneration
Capacity, Inflammation Response and Oxidative Stress. PLoS One
10:e0128567. doi:10.1371/journal.pone.0128567
Manabe Y, Takagi M, Nakamura-Yamada M, Goto-Inoue N, Taoka
M, Isobe T, Fujii NL (2014) Redox proteins are constitutively
secreted by skeletal muscle. J Physiol Sci 64:401–409. doi:10.
1007/s12576-014-0334-7
Manzur AY, Muntoni F (2009) Diagnosis and new treatments in
muscular dystrophies. Postgrad Med J 85:622–630. doi:10.1136/
jnnp.2008.158329
Matsumura CY, de Menezes OB, Durbeej M, Marques MJ (2013)
Isobaric tagging-based quantification for proteomic analysis: a
comparative study of spared and affected muscles from mice at
the early phase of dystrophy. PLoS One 8:e65831. doi:10.1371/
journal.pone.0065831
Mechler F, Imre S, Dioszeghy P (1984) Lipid peroxidation and
superoxide dismutase activity in muscle and erythrocytes in
Duchenne muscular dystrophy. J Neurol Sci 63:279–283
Mendell JR, Engel WK, Derrer EC (1971) Duchenne muscular
dystrophy: functional ischemia reproduces its characteristic
lesions. Science 172:1143–1145
Messina S, Altavilla D, AguennouzM, Seminara P, Minutoli L, Monici
MC, Bitto A, Mazzeo A, Marini H, Squadrito F, Vita G (2006)
Lipid peroxidation inhibition blunts nuclear factor-kappaB acti-
vation, reduces skeletal muscle degeneration, and enhances
muscle function in mdx mice. Am J Pathol 168:918–926
Messina S, Bitto A, Aguennouz M, Mazzeo A, Migliorato A, Polito F,
Irrera N,Altavilla D,Vita GL, RussoM,NaroA,De PasqualeMG,
Rizzuto E, Musaro A, Squadrito F, Vita G (2009) Flavocoxid
counteracts muscle necrosis and improves functional properties in
mdx mice: a comparison study with methylprednisolone. Exp
Neurol 220:349–358. doi:10.1016/j.expneurol.2009.09.015
Miller CJ, Gounder SS, Kannan S, Goutam K, Muthusamy VR, Firpo
MA, Symons JD, Paine R III, Hoidal JR, Rajasekaran NS (2012)
Disruption of Nrf2/ARE signaling impairs antioxidant mecha-
nisms and promotes cell degradation pathways in aged skeletal
muscle. Biochim Biophys Acta 1822:1038–1050. doi:10.1016/j.
bbadis.2012.02.007
Montarras D, L’honore A, Buckingham M (2013) Lying low but
ready for action: the quiescent muscle satellite cell. FEBS J
280:4036–4050. doi:10.1111/febs.12372
Mourkioti F, Kratsios P, Luedde T, Song YH, Delafontaine P, Adami
R, Parente V, Bottinelli R, Pasparakis M, Rosenthal N (2006)
Targeted ablation of IKK2 improves skeletal muscle strength,
maintains mass, and promotes regeneration. J Clin Invest
116:2945–2954. doi:10.1172/JCI28721
Muller FL, Song W, Liu Y, Chaudhuri A, Pieke-Dahl S, Strong R,
Huang TT, Epstein CJ, Roberts LJ, Csete M, Faulkner JA, Van
RH (2006) Absence of CuZn superoxide dismutase leads to
elevated oxidative stress and acceleration of age-dependent
skeletal muscle atrophy. Free Radic Biol Med 40:1993–2004.
doi:10.1016/j.freeradbiomed.2006.01.036
Murdoch CE, Shuler M, Haeussler DJ, Kikuchi R, Bearelly P, Han J,
Watanabe Y, Fuster JJ, Walsh K, Ho YS, Bachschmid MM,
Cohen RA, Matsui R (2014) Glutaredoxin-1 up-regulation
induces soluble vascular endothelial growth factor receptor 1,
attenuating post-ischemia limb revascularization. J Biol Chem
289:8633–8644. doi:10.1074/jbc.M113.517219
Myburgh KH, Kruger MJ, Smith C (2012) Accelerated skeletal
muscle recovery after in vivo polyphenol administration. J Nutr
Biochem 23:1072–1079. doi:10.1016/j.jnutbio.2011.05.014
Naito Y, Takagi T, Higashimura Y (2014) Heme oxygenase-1 and
anti-inflammatory M2 macrophages. Arch Biochem Biophys
564:83–88. doi:10.1016/j.abb.2014.09.005
Nakae Y, Dorchies OM, Stoward PJ, Zimmermann BF, Ritter C,
Ruegg UT (2012) Quantitative evaluation of the beneficial
effects in the mdx mouse of epigallocatechin gallate, an
antioxidant polyphenol from green tea. Histochem Cell Biol
137:811–827. doi:10.1007/s00418-012-0926-3
390 J Muscle Res Cell Motil (2015) 36:377–393
123
Nishida H, Ichikawa H, Konishi T (2007) Shengmai-san enhances
antioxidant potential in C2C12 myoblasts through the induction of
intracellular glutathione peroxidase. J Pharmacol Sci 105:342–352
Novak ML, Koh TJ (2013) Phenotypic transitions of macrophages
orchestrate tissue repair. Am J Pathol 183:1352–1363. doi:10.
1016/j.ajpath.2013.06.034
Odemis V, BoosmannK, DieterlenMT, Engele J (2007) The chemokine
SDF1 controls multiple steps of myogenesis through atypical
PKCzeta. J Cell Sci 120:4050–4059. doi:10.1242/jcs.010009
Oshikawa J, Urao N, Kim HW, Kaplan N, Razvi M, McKinney R,
Poole LB, Fukai T, Ushio-Fukai M (2010) Extracellular SOD-
derived H2O2 promotes VEGF signaling in caveolae/lipid rafts
and post-ischemic angiogenesis in mice. PLoS One 5:e10189.
doi:10.1371/journal.pone.0010189
Padgett LE, Burg AR, Lei W, Tse HM (2015) Loss of NADPH
oxidase-derived superoxide skews macrophage phenotypes to
delay type 1 diabetes. Diabetes 64:937–946. doi:10.2337/db14-
0929
Pal R, Palmieri M, Loehr JA, Li S, Abo-Zahrah R, Monroe TO,
Thakur PB, Sardiello M, Rodney GG (2014) Src-dependent
impairment of autophagy by oxidative stress in a mouse model
of Duchenne muscular dystrophy. Nat Commun 5:4425. doi:10.
1038/ncomms5425
Pallafacchina G, Francois S, Regnault B, Czarny B, Dive V, Cumano
A, Montarras D, Buckingham M (2010) An adult tissue-specific
stem cell in its niche: a gene profiling analysis of in vivo
quiescent and activated muscle satellite cells. Stem Cell Res
4:77–91. doi:10.1016/j.scr.2009.10.003
Pattwell DM, Jackson MJ (2004) Contraction-induced oxidants as
mediators of adaptation and damage in skeletal muscle. Exerc
Sport Sci Rev 32:14–18
Pawlikowska P, Gajkowska B, Hocquette JF, Orzechowski A (2006)
Not only insulin stimulates mitochondriogenesis in muscle cells,
but mitochondria are also essential for insulin-mediated myoge-
nesis. Cell Prolif 39:127–145. doi:10.1111/j.1365-2184.2006.
00376.x
Petrof BJ, Stedman HH, Shrager JB, Eby J, Sweeney HL, Kelly AM
(1993) Adaptations in myosin heavy chain expression and
contractile function in dystrophic mouse diaphragm. Am J
Physiol 265:C834–C841
Pietarinen-Runtti P, Lakari E, Raivio KO, Kinnula VL (2000)
Expression of antioxidant enzymes in human inflammatory cells.
Am J Physiol Cell Physiol 278:C118–C125
Pilegaard H, Ordway GA, Saltin B, Neufer PD (2000) Transcriptional
regulation of gene expression in human skeletal muscle during
recovery from exercise. Am J Physiol Endocrinol Metab
279:E806–E814
Pillon NJ, Bilan PJ, Fink LN, Klip A (2013) Cross-talk between
skeletal muscle and immune cells: muscle-derived mediators and
metabolic implications. Am J Physiol Endocrinol Metab
304:E453–E465. doi:10.1152/ajpendo.00553.2012
Powers SK, Criswell D, Lawler J, Ji LL, Martin D, Herb RA, Dudley
G (1994) Influence of exercise and fiber type on antioxidant
enzyme activity in rat skeletal muscle. Am J Physiol 266:R375–
R380
Powers SK, Duarte J, Kavazis AN, Talbert EE (2010) Reactive
oxygen species are signalling molecules for skeletal muscle
adaptation. Exp Physiol 95:1–9. doi:10.1113/expphysiol.2009.
050526
Powers SK, Ji LL, Kavazis AN, Jackson MJ (2011) Reactive oxygen
species: impact on skeletal muscle. Compr Physiol 1:941–969.
doi:10.1002/cphy.c100054
Primeau AJ, Adhihetty PJ, Hood DA (2002) Apoptosis in heart and
skeletal muscle. Can J Appl Physiol 27:349–395
Radley HG, Grounds MD (2006) Cromolyn administration (to block
mast cell degranulation) reduces necrosis of dystrophic muscle
in mdx mice. Neurobiol Dis 23:387–397. doi:10.1016/j.nbd.
2006.03.016
Ragusa RJ, Chow CK, Porter JD (1997) Oxidative stress as a potential
pathogenic mechanism in an animal model of Duchenne
muscular dystrophy. Neuromuscul Disord 7:379–386
Rajakumar D, Alexander M, Oommen A (2013) Oxidative stress, NF-
kappaB and the ubiquitin proteasomal pathway in the pathology
of calpainopathy. Neurochem Res 38:2009–2018. doi:10.1007/
s11064-013-1107-z
Rando TA (2001) The dystrophin-glycoprotein complex, cellular
signaling, and the regulation of cell survival in the muscular
dystrophies. Muscle Nerve 24:1575–1594
Rando TA (2002) Oxidative stress and the pathogenesis of muscular
dystrophies. Am J Phys Med Rehabil 81:S175–S186. doi:10.
1097/01.PHM.0000029774.56528.A6
Rando TA, Crowley RS, Carlson EJ, Epstein CJ, Mohapatra PK
(1998a) Overexpression of copper/zinc superoxide dismutase: a
novel cause of murine muscular dystrophy. Ann Neurol
44:381–386. doi:10.1002/ana.410440315
Rando TA, Disatnik MH, Yu Y, Franco A (1998b) Muscle cells from
mdx mice have an increased susceptibility to oxidative stress.
Neuromuscul Disord 8:14–21
Reay DP, Yang M, Watchko JF, Daood M, O’Day TL, Rehman KK,
Guttridge DC, Robbins PD, Clemens PR (2011) Systemic
delivery of NEMO binding domain/IKKgamma inhibitory pep-
tide to young mdx mice improves dystrophic skeletal muscle
histopathology. Neurobiol Dis 43:598–608. doi:10.1016/j.nbd.
2011.05.008
Relaix F, Zammit PS (2012) Satellite cells are essential for skeletal
muscle regeneration: the cell on the edge returns centre stage.
Development 139:2845–2856. doi:10.1242/dev.069088
Renjini R, Gayathri N, Nalini A, Srinivas Bharath MM (2012)
Oxidative damage in muscular dystrophy correlates with the
severity of the pathology: role of glutathione metabolism.
Neurochem Res 37:885–898. doi:10.1007/s11064-011-0683-z
Rochard P, Rodier A, Casas F, Cassar-Malek I, Marchal-Victorion S,
Daury L, Wrutniak C, Cabello G (2000) Mitochondrial activity
is involved in the regulation of myoblast differentiation through
myogenin expression and activity of myogenic factors. J Biol
Chem 275:2733–2744
Rodriguez MC, Tarnopolsky MA (2003) Patients with dystrophinopa-
thy show evidence of increased oxidative stress. Free Radic Biol
Med 34:1217–1220
Rodriguez-BiesE,Navas P,Lopez-LluchG (2015)Age-dependent effect
of every-other-day feeding and aerobic exercise in ubiquinone
levels and relatedantioxidant activities inmicemuscle. JGerontolA
Biol Sci Med Sci 70:33–43. doi:10.1093/gerona/glu002
Saclier M, Cuvellier S, Magnan M, Mounier R, Chazaud B (2013)
Monocyte/macrophage interactions with myogenic precursor
cells during skeletal muscle regeneration. FEBS J 280:4118–
4130. doi:10.1111/febs.12166
Sakellariou GK, Vasilaki A, Palomero J, Kayani A, Zibrik L,
McArdle A, Jackson MJ (2013) Studies of mitochondrial and
nonmitochondrial sources implicate nicotinamide adenine dinu-
cleotide phosphate oxidase(s) in the increased skeletal muscle
superoxide generation that occurs during contractile activity.
Antioxid Redox Signal 18:603–621. doi:10.1089/ars.2012.4623
Sakellariou GK, Jackson MJ, Vasilaki A (2014) Redefining the major
contributors to superoxide production in contracting skeletal
muscle. The role of NAD(P)H oxidases. Free Radic Res
48:12–29. doi:10.3109/10715762.2013.830718
Sandiford SD, Kennedy KA, Xie X, Pickering JG, Li SS (2014) Dual
oxidase maturation factor 1 (DUOXA1) overexpression
increases reactive oxygen species production and inhibits murine
muscle satellite cell differentiation. Cell Commun Signal 12:5.
doi:10.1186/1478-811X-12-5
J Muscle Res Cell Motil (2015) 36:377–393 391
123
Saxena S, Shukla D, Saxena S, Khan YA, Singh M, Bansal A, Sairam
M, Jain SK (2010) Hypoxia preconditioning by cobalt chloride
enhances endurance performance and protects skeletal muscles
from exercise-induced oxidative damage in rats. Acta Physiol
(Oxf) 200:249–263. doi:10.1111/j.1748-1716.2010.02136.x
Sciancalepore M, Luin E, Parato G, Ren E, Giniatullin R, Fabbretti E,
Lorenzon P (2012) Reactive oxygen species contribute to the
promotion of the ATP-mediated proliferation of mouse skeletal
myoblasts. Free Radic Biol Med 53:1392–1398. doi:10.1016/j.
freeradbiomed.2012.08.002
Selsby JT (2011) Increased catalase expression improves muscle
function in mdx mice. Exp Physiol 96:194–202. doi:10.1113/
expphysiol.2010.054379
Sen CK (1995) Oxidants and antioxidants in exercise. J Appl Physiol
79:675–686
Sen CK, Marin E, Kretzschmar M, Hanninen O (1992) Skeletal
muscle and liver glutathione homeostasis in response to training,
exercise, and immobilization. J Appl Physiol 73:1265–1272
Sestili P, Barbieri E, Martinelli C, Battistelli M, Guescini M,
Vallorani L, Casadei L, D’Emilio A, Falcieri E, Piccoli G,
Agostini D, Annibalini G, Paolillo M, Gioacchini AM, Stocchi V
(2009) Creatine supplementation prevents the inhibition of
myogenic differentiation in oxidatively injured C2C12 murine
myoblasts. Mol Nutr Food Res 53:1187–1204. doi:10.1002/mnfr.
200800504
Silvestre JS, Smadja DM, Levy BI (2013) Postischemic revascular-
ization: from cellular and molecular mechanisms to clinical
applications. Physiol Rev 93:1743–1802. doi:10.1152/physrev.
00006.2013
Singh S, Canseco DC, Manda SM, Shelton JM, Chirumamilla RR,
Goetsch SC, Ye Q, Gerard RD, Schneider JW, Richardson JA,
Rothermel BA, Mammen PP (2014) Cytoglobin modulates
myogenic progenitor cell viability and muscle regeneration. Proc
Natl Acad Sci U S A 111:E129–E138. doi:10.1073/pnas.
1314962111
Spencer MJ, Tidball JG (2001) Do immune cells promote the
pathology of dystrophin-deficient myopathies? Neuromuscul
Disord 11:556–564
Spurney CF, Knoblach S, Pistilli EE, Nagaraju K, Martin GR,
Hoffman EP (2008) Dystrophin-deficient cardiomyopathy in
mouse: expression of Nox4 and Lox are associated with fibrosis
and altered functional parameters in the heart. Neuromuscul
Disord 18:371–381. doi:10.1016/j.nmd.2008.03.008
Stachurska A, Ciesla M, Kozakowska M, Wolffram S, Boesch-
Saadatmandi C, Rimbach G, Jozkowicz A, Dulak J, Loboda A
(2013) Cross-talk between microRNAs, nuclear factor E2-related
factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic
effects in renal proximal tubular epithelial cells. Mol Nutr Food
Res 57:504–515. doi:10.1002/mnfr.201200456
Stocker R (2004) Antioxidant activities of bile pigments. Antioxid
Redox Signal 6:841–849. doi:10.1089/ars.2004.6.841
Stone JR, Yang S (2006) Hydrogen peroxide: a signaling messenger.
Antioxid Redox Signal 8:243–270. doi:10.1089/ars.2006.8.243
SunCC,Li SJ,YangCL,XueRL,XiYY,WangL, ZhaoQL,Li J (2015)
Sulforaphane attenuates muscle inflammation in dystrophin-
deficient Mdx mice via Nrf2-mediated inhibition of NF-kappaB
signaling pathway. J Biol Chem. doi:10.1074/jbc.M115.655019
Suzuki K, Murtuza B, Beauchamp JR, Smolenski RT, Varela-Carver
A, Fukushima S, Coppen SR, Partridge TA, Yacoub MH (2004)
Dynamics and mediators of acute graft attrition after myoblast
transplantation to the heart. FASEB J 18:1153–1155. doi:10.
1096/fj.03-1308fje
Terrill JR, Radley-Crabb HG, Iwasaki T, Lemckert FA, Arthur PG,
Grounds MD (2013) Oxidative stress and pathology in muscular
dystrophies: focus on protein thiol oxidation and dysfer-
linopathies. FEBS J 280:4149–4164. doi:10.1111/febs.12142
Thaloor D, Miller KJ, Gephart J, Mitchell PO, Pavlath GK (1999)
Systemic administration of the NF-kappaB inhibitor curcumin
stimulates muscle regeneration after traumatic injury. Am J
Physiol 277:C320–C329
Tidball JG (2011) Mechanisms of muscle injury, repair, and
regeneration. Compr Physiol 1:2029–2062. doi:10.1002/cphy.
c100092
Tidball JG, Wehling-Henricks M (2004) Evolving therapeutic strate-
gies for Duchenne muscular dystrophy: targeting downstream
events. Pediatr Res 56:831–841. doi:10.1203/01.PDR.
0000145578.01985.D0
Tidball JG, Wehling-Henricks M (2007) The role of free radicals in
the pathophysiology of muscular dystrophy. J Appl Physiol
102:1677–1686. doi:10.1152/japplphysiol.01145.2006
Togliatto G, Trombetta A, Dentelli P, Cotogni P, Rosso A, Tschop
MH, Granata R, Ghigo E, Brizzi MF (2013) Unacylated ghrelin
promotes skeletal muscle regeneration following hindlimb
ischemia via SOD-2-mediated miR-221/222 expression. J Am
Heart Assoc. doi:10.1161/JAHA.113.000376
Tongers J, Knapp JM, Korf M, Kempf T, Limbourg A, Limbourg FP,
Li Z, Fraccarollo D, Bauersachs J, Han X, Drexler H, Fiedler B,
Wollert KC (2008) Haeme oxygenase promotes progenitor cell
mobilization, neovascularization, and functional recovery after
critical hindlimb ischaemia in mice. Cardiovasc Res
78:294–300. doi:10.1093/cvr/cvm107
Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P (2008)
Redox regulation of cell survival. Antioxid Redox Signal
10:1343–1374. doi:10.1089/ars.2007.1957
Urish KL, Vella JB, Okada M, Deasy BM, Tobita K, Keller BB, Cao
B, Piganelli JD, Huard J (2009) Antioxidant levels represent a
major determinant in the regenerative capacity of muscle stem
cells. Mol Biol Cell 20:509–520. doi:10.1091/mbc.E08-03-0274
Vasilaki A, Jackson MJ (2013) Role of reactive oxygen species in the
defective regeneration seen in aging muscle. Free Radic Biol
Med 65:317–323. doi:10.1016/j.freeradbiomed.2013.07.008
Vasilaki A, Csete M, Pye D, Lee S, Palomero J, McArdle F, Van RH,
Richardson A, McArdle A, Faulkner JA, Jackson MJ (2006a)
Genetic modification of the manganese superoxide dismutase/
glutathione peroxidase 1 pathway influences intracellular ROS
generation in quiescent, but not contracting, skeletal muscle
cells. Free Radic Biol Med 41:1719–1725. doi:10.1016/j.free
radbiomed.2006.09.008
Vasilaki A, McArdle F, Iwanejko LM, McArdle A (2006b) Adaptive
responses of mouse skeletal muscle to contractile activity: the
effect of age. Mech Ageing Dev 127:830–839. doi:10.1016/j.
mad.2006.08.004
Vercherat C, Chung TK, Yalcin S, Gulbagci N, Gopinadhan S,
Ghaffari S, Taneja R (2009) Stra13 regulates oxidative stress
mediated skeletal muscle degeneration. Hum Mol Genet
18:4304–4316. doi:10.1093/hmg/ddp383
Vezzoli M, Castellani P, Corna G, Castiglioni A, Bosurgi L, Monno
A, Brunelli S, Manfredi AA, Rubartelli A, Rovere-Querini P
(2011) High-mobility group box 1 release and redox regulation
accompany regeneration and remodeling of skeletal muscle.
Antioxid Redox Signal 15:2161–2174. doi:10.1089/ars.2010.
3341
Wagatsuma A, Kotake N, Yamada S (2011) Muscle regeneration
occurs to coincide with mitochondrial biogenesis. Mol Cell
Biochem 349:139–147. doi:10.1007/s11010-010-0668-2
Wang H, Hertlein E, Bakkar N, Sun H, Acharyya S, Wang J,
Carathers M, Davuluri R, Guttridge DC (2007) NF-kappaB
regulation of YY1 inhibits skeletal myogenesis through tran-
scriptional silencing of myofibrillar genes. Mol Cell Biol
27:4374–4387. doi:10.1128/MCB.02020-06
Wang R, Luo D, Xiao C, Lin P, Liu S, Xu Q, Wang Y (2013) The
time course effects of electroacupuncture on promoting skeletal
392 J Muscle Res Cell Motil (2015) 36:377–393
123
muscle regeneration and inhibiting excessive fibrosis after
contusion in rabbits. Evid Based Complement Alternat Med
2013:869398. doi:10.1155/2013/869398
Warren GL, Hayes DA, Lowe DA, Prior BM, Armstrong RB (1993)
Materials fatigue initiates eccentric contraction-induced injury in
rat soleus muscle. J Physiol 464:477–489
West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H,
Tempst P, Walsh MC, Choi Y, Shadel GS, Ghosh S (2011) TLR
signalling augments macrophage bactericidal activity through
mitochondrial ROS. Nature 472:476–480. doi:10.1038/
nature09973
Whitehead NP, Yeung EW, Allen DG (2006) Muscle damage in mdx
(dystrophic) mice: role of calcium and reactive oxygen species.
Clin Exp Pharmacol Physiol 33:657–662. doi:10.1111/j.1440-
1681.2006.04394.x
Whitehead NP, Pham C, Gervasio OL, Allen DG (2008) N-Acetyl-
cysteine ameliorates skeletal muscle pathophysiology in mdx
mice. J Physiol 586:2003–2014. doi:10.1113/jphysiol.2007.
148338
Williams IA, Allen DG (2007) The role of reactive oxygen species in
the hearts of dystrophin-deficient mdx mice. Am J Physiol Heart
Circ Physiol 293:H1969–H1977. doi:10.1152/ajpheart.00489.
2007
Wilson HM, Welikson RE, Luo J, Kean TJ, Cao B, Dennis JE, Allen
MD (2015) Can cytoprotective cobalt protoporphyrin protect
skeletal muscle and muscle-derived stem cells from ischemic
injury? Clin Orthop Relat Res. doi:10.1007/s11999-015-4332-8
Won H, Lim S, Jang M, Kim Y, Rashid MA, Jyothi KR, Dashdorj A,
Kang I, Ha J, Kim SS (2012) Peroxiredoxin-2 upregulated by
NF-kappaB attenuates oxidative stress during the differentiation
of muscle-derived C2C12 cells. Antioxid Redox Signal
16:245–261. doi:10.1089/ars.2011.3952
Yin H, Price F, Rudnicki MA (2013) Satellite cells and the muscle
stem cell niche. Physiol Rev 93:23–67. doi:10.1152/physrev.
00043.2011
Yu BP (1994) Cellular defenses against damage from reactive oxygen
species. Physiol Rev 74:139–162
Zhang Y, Choksi S, Chen K, Pobezinskaya Y, Linnoila I, Liu ZG
(2013) ROS play a critical role in the differentiation of
alternatively activated macrophages and the occurrence of
tumor-associated macrophages. Cell Res 23:898–914. doi:10.
1038/cr.2013.75
Zhou LZ, Johnson AP, Rando TA (2001) NF kappa B and AP-1
mediate transcriptional responses to oxidative stress in skeletal
muscle cells. Free Radic Biol Med 31:1405–1416
Zuo L, Christofi FL, Wright VP, Bao S, Clanton TL (2004)
Lipoxygenase-dependent superoxide release in skeletal muscle.
J Appl Physiol 97:661–668. doi:10.1152/japplphysiol.00096.
2004
J Muscle Res Cell Motil (2015) 36:377–393 393
123
